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1 Abbreviations 
Note the following abbreviations are used throughout this study: 
AA Amino acids 
Ab Antibody 
ABP Activity-based probe 
ABPP Activity-based protein profiling 
ACN Acetonitrile 
APS Ammonium persulfate 
BSA Bovine serum albumin 
CIEX Cation exchange 
Da Dalton 
DNA Deoxyribonucleic acid 
DTT Dithiothreitol 
DUB Deubiquitinating enzyme 
E1 Ubiquitin activating enzyme 
E2 Ubiquitin conjugating enzyme 
E3 Ubiquitin ligase 
ECL Enhanced chemoluminescence 
EDTA Ethylenediaminetetraacetic acid 
FA Formic acid 
FBS Fetal bovine serum 
E-cadherin Epithelial cadherin 
HA Hemagglutinin 
HA-Ub Ubiquitin tagged with YPYDVPDYA ( HA-tag) 
HAUbMF HA-ubiquitin glycine vinylmonofluorethylamide probe 
HAUbVME HA-ubiquitin glycine vinylmethylester probe 
HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid 
HPA The Human Protein Atlas 
HZI Helmholtz Zentrum für Infektionsforschung 
IGEPAL Octylphenoxypolyethoxyethanol 
IP Immunoprecipitation 
JAMM JAB1/MPN/Mov34 metalloenzyme domain 
K Lysine (Lys) 
MALDI Matrix-assisted laser desorption/ionization 
MESNa 2-Mercaptoethane sulfonate with coordinated sodium 
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MJD Machado-Josephin disease domain 
mRNA Messenger RNA 
MW Molecular weight [Da] 
NY Nylon 
OTU Ovarian tumor domain 
PBS Phosphate buffered saline 
PEG Polyethylene glycol 
ppm Parts per million 
RNA Ribonucleic acid 
rpm Rounds per minute 
RT Room temperature 
SDS Sodium dodecyl sulfate 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
S-NHS Sulfo-N-hydroxysulfosuccinimide 
TEMED N, N, N', N' -tetramethylethylenediamide 
TFA Trifluoroacetic Acid 
TOF Time of flight 
Tris N-tris(Hydroxymethyl)-methylglycine 
Tween20 Polyethylene glycol sorbitan monolaurate (connectivity 20) 
Ub Ubiquitin 
UBL Ubiquitin-like protein 
UCH Ubiquitin C-terminal hydrolase 
UIPP Ubiquitin isopeptide probe 
USP Ubiquitin-specific protease 
UV Ultra violet 
v/v Volume per volume 
VME Vinyl methyl ester 
VS Vinyl methyl sulfone 
w/v Weight per volume 
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Aims 
The posttranslational modification of proteins by ubiquitin (Ub) is a reversible process 
and coordinates the stability, turn-over and localization of protein substrates and also 
alters important protein-protein interactions. Deubiquitinating proteases (DUBs) 
remove specifically the conjugated ubiquitin from modified proteins and thus are able 
to direct the fate of the protein. Their catalytic mechanism and the ability to regulate 
various cellular events render this enzyme class to an attractive drug target.  
In contrast to their general importance, their distribution in different cell types and 
tissues as well as the question of how they achieve substrate specificity is poorly 
understood at this time. Functional proteomics utilizing activity based probes (ABPs) 
has shown great potential in the annotation of DUB function and to obtain access to 
previously uncharacterized members of this enzyme class. Novel ABPs could serve 
as targeted research tools to assign biochemical and physiological functions of 
known and poorly characterized DUBs.  
 
The aim of this study was the improvement of current activity based probes (ABPs) to 
increase specificity towards DUBs. The first intent was the improvement of ubiquitin 
derived ABPs by systematic modulation of HAUb-VME as the gold standard probe, 
while providing information on significant parameters determining its reactivity 
towards DUB proteases. The second aim of this thesis was the development of a 
completely new approach for the generation of a novel class of ubiquitin probes, 
which are able to dissect ubiquitin-linkage specificity and substrate preference of 
targeted DUBs. 
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2 Introduction 
Regulation of protein function is often mediated by the reversible attachment of 
chemical modifiers, such as phosphate or acetyl groups. Ubiquitin can also modify 
other proteins and influence their function and half-life in several ways.  
The posttranslational modification of proteins by ubiquitin (Ub) and ubiquitin-like (Ubl) 
modifiers is a reversible process and is involved in many signal transduction 
pathways1,2. Deubiquitinating enzymes (DUBs) remove covalently bound Ub and Ubl 
moieties from modified proteins. Apart from mono- and multi-ubiquitination, further 
ubiquitination diversity is achieved by the assembly of poly-Ub chains, such as Lys48 
(K48)- and Lys63 (K63)-linked Ub chains. 
Many detailed reviews on DUBs have been published in recent years, describing 
their implication in various cellular functions like proteasome-dependent protein 
degradation3, cell cycle regulation4, gene expression5 and in regulating kinase 
activity6. Thereby, because of their potential to regulate important cellular processes, 
malfunction of many DUBs have been implicated in several diseases including 
inflammatory diseases7, Fanconi anemia, neurodegenerative diseases and cancer8,9. 
In addition to these highly regulated cellular processes, a number of studies reported 
pathogenic microorganisms with genes encoding DUBs, which very likely provide an 
advantage for certain viruses like HSV-110 or bacteria such Chlamydia or 
Salmonella11. Thus, recent studies identified a protease in Chlamydia trachomatis 
which was detected with an activity-based probe (ABP) and indeed represents the 
first known bacterial DUB that possesses both deubiquitinating and deneddylating 
activities12. Deubiquitination also occurs in virus infections13 like Epstein-Barr virus 
and is executed by three bona fide ubiquitin-specific proteases14. 
Thus, the activities of deubiquitinating enzymes have to be precisely regulated to 
prevent missing or inappropriate Ub cleavages and to ensure the equilibrium in the 
ubiquitin system. In order to recognize this regulation, more studies are needed to 
understand the unexplored mechanisms of specificity of DUBs towards their 
substrates and ubiquitin or ubiquitin-like proteins. In the last decades it was shown 
that DUBs contain not only catalytic domains but also various ubiquitin-binding and 
protein-protein interaction domains. These domains assist in the selective binding of 
Ub-linkages and the assembly of multi-functional protein complexes, which also 
contribute to their localization and substrate specificity15. The investigation of DUB 
specificity is clearly focused, but still poorly understood due to the complex multiple 
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mode of actions and the restrictions to in vitro assays. In spite of the paucity of 
knowledge about DUB mechanisms and regulations, some drugs have already been 
successfully tested in clinical trials. However, novel DUB characterization tools will 
certainly provide significant information to advance the drug discovery with greater 
strides.  
 Most of the current tools are in vitro assays that aim to capture a wide range of 
DUBs or to test the deubiquitinating activity, rather than investigating their catalytic 
mechanism and Ub-linkage specificity in vivo. 
Considering DUBs multiple actions as described above, the comparison of absolute 
activities in a biological environment can shed light on DUB regulation and its 
substrate specificity. This is especially important when a DUB shows preference for 
multiple substrates with different efficiencies. For example, an in vitro cleavage assay 
with K48- and K63-linked Ub chains subjected to USP5 would show the cleavage of 
both chains16, due to the multiple substrate specificity of this DUB. Information about 
its relative substrate preferences and the course of reaction in a more natural 
environment could not be determined with this in vitro strategy. To understand the 
mode of action in more detail, the development of activity-based selective and 
quantitative binding assays in vivo is required. This present study will introduce DUBs 
functionality in more detail and will discuss how chemical tools, such as activity 
based site-directed probes, can facilitate the discovery of further deubiquitinating 
enzymes, their functional profiling, advances in crystallography and understanding of 
catalytic mechanisms.  
After the introduction of these powerful tools, the new generation of ABPs developed 
in this study and their upgrading possibility will be presented.  
Finally, in order to address the complex selectivity of DUBs novel selective Ubiquitin 
Isopeptide Activity-Based Probe (UIPPs) were engineered to characterize the 
molecular basis of DUB target specificities for the first time.  
Briefly, the novel UIPPs described here can be used as a tool to characterize 
previously unknown target specificities of DUBs, enable their detailed mechanistic 
characterization and deduce their importance in various infectious diseases.  
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2.1 Ubiquitin 
Ubiquitin (Ub) is a small 76 amino acid (AA) protein which is named according to its 
extraordinarily ubiquitous distribution and high conservation in eukaryotes.  
Ubiquitin is translated as a linear fusion construct containing multiple ubiquitins or is 
fused to ribosomal proteins. Ub is resistant and stable at extreme temperatures and 
pH values as well as high salt concentrations17. However, ubiquitin has a finite half-
life and is removed by ATP-dependent proteasomal degradation (see Ubiquitin-
Proteasome-System section). In a posttranslational enzyme-catalyzed process it is 
able to form covalent bonds with a variety of cellular proteins. Ubiquitin is expressed 
as an inactive precursor and consists either of head-to-tail repeats of the ubiquitin or 
is expressed as a fusion protein, like small ribosomal subunits18,19. Monomeric 
ubiquitin is released through the activity of ubiquitin-specific proteases, which cleave 
after the C-terminal di-glycine motif. This resulting free C-terminal is then able to form 
an isopeptide bond with the ε-amino group of lysine residues of a target protein, a 
process termed ubiquitination. In distinct cases the ubiquitination also occurs at the 
N-terminus of the substrate20. The ubiquitin sequence contains seven lysine (K) 
residues (Figure 1) and is thus capable to be ubiquitinated itself 21. Although ubiquitin 
abundance varies in different conditions and within different tissues, the ratio of 
monoubiquitin to conjugated ubiquitin is approximately 1/1. 
 
 
Figure 1. Ribbon and surface illustration 
of functionally relevant features of the Ub 
structure. (a) Ubiquitin structure with 
seven internal lysine residues (shown in 
grey as sticks) used to build up Ub-
linkages. (b) The same ubiquitin 
molecule is shown as surface 
representation with additional labeling of 
the C-terminus  (LRGG-motif in yellow). 
The pictures were generated using The 
PyMOL Molecular Graphics System, 
DeLano Scientific LLC, Palo Alto, CA, 2008, PDB-ID: 1UBQ). 
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2.1.1 Ubiquitin Linkages 
It is important to underline that a target protein can be modified by ubiquitin in several 
ways, by mono-, di-, multi-, or polyubiquitination (Figure 2). However, a combination 
of these types cannot be excluded. Monoubiquitination is the conjugation of one 
single ubiquitin with its target protein and is involved in processes like signal 
transduction, endocytosis and by modulation of protein activity. Di- and multi-
ubiquitination is the modification of one protein with several single ubiquitins on 
separate lysine residues and is implicated for instance in the formation of 
multivesicular bodies, protein localization and modulation of protein activities. 
Polyubiquitination is the result of sequential attachment of ubiquitin moieties to the 
proximal ubiquitin through their lysine residues as described above. The basic 
process for ubiquitination and polyubiquitination is carried out by an enzyme cascade 
and will be described in chapter 2.2.1. 
 
 
Figure 2. Possible ubiquitin modifications and their effect on the fate and function of the modified 
proteins. Monoubiquitination is the conjugation of one ubiquitin to a single lysine -and 
multiubiquitination the modification of various lysine residues on the target protein. These 
modifications have been implicated in cellular processes such as transcription regulation, membrane 
trafficking, DNA repair and DNA replication. Repeated ubiquitination of the first ubiquitin on the target 
protein results in polyubiquitin chains, which differ in their topology depending on the lysine residue 
chosen on the proximal ubiquitin. The topology of the polyubiquitin chains define the fate of the target 
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protein in different cellular processes like degradation, cellular localization, protein activation and 
diverse interactions in signaling (Ye & Rape 2009). 
 
 
Since ubiquitin itself contains seven lysine residues (K6, K11, K27, K29, K33, K48 
and K63) at least seven different topologically different polyubiquitin chains are 
possible and contribute to diverse functional effects (Figure 2).  
Recently, mass spectrometry analysis revealed the relative abundance of 
polyubiquitin chains as following: Lys48 > Lys11 > Lys63>> Lys6, Lys27, Lys29 and Lys33 
22. In addition to these homotypic polyubiquitin chains, also heterogeneously forked 
chains containing two different Ub-linkage types are possible and were observed for 
Lys6+Lys11, Lys27+Lys29, Lys29+Lys33 
23. Considering that polyubiquitin chains can 
split and form branches, even more topologies and functions of polyubiquitin chains 
can be expected24. Furthermore, the combination of other Ubl modifiers with ubiquitin 
chains results in even more heterogeneous chains and was recently observed for 
SUMO-Ub combinations25,26. 
However, Lys48 - and Lys63 - linked polyubiquitin chains are well studied and have 
been shown to affect many cellular functions. While Lys48-linked chains with more 
than four ubiquitin moieties in length target the substrate for proteasomal proteolysis, 
the Lys63-linkages serve for non-proteolytical functions including cellular signaling, 
DNA repair and lysosomal targeting27,28. Furthermore, recent studies refer to K63–
polyubiquitin modifications as docking sites for adapter proteins in the NF-kappaB 
signaling pathway29. From the structural point of view, the linear polyubiquitin chains 
are similar to the K63 –polyubiquitin
30 and are also interestingly found in the NF-
kappaB pathway28. Concerning the K11-linked chains, recent observations showed 
surprising similarities to K48-polyubiquitin chains by targeting proteins to proteasomal 
and endoplasmatic reticulum-associated proteolysis 31,32. 
In respect of another polyubiquitin chains formed through Lys6, Lys27, Lys29 and 
Lys33, there is not much known which demonstrates the discovery need and the 
potential of further putative unique regulatory insights. 
Although scientists are working intensively on the structural characterization of these 
different Ub-linkages, only three Ub-linkages (K11, K48, K63) have been described 
well to date. It is importantly to note that, beside the crystal structures also NMR 
studies were performed, however, they were not always consistent33. For example, 
concerning different pH conditions, the polyubiquitin structures differ extremely34 as 
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demonstrated for K48- di-ubiquitin in Figure 3. In addition to different structural 
conformations between in vitro and in vivo studies it is also important to know the 
localization of certain polyubiquitin chains in the cell.  
 
 
 
Figure 3. NMR spectroscopy of solution conformations of K48- and K63 -linked di-ubiquitin at different 
pH conditions. Solution conformation of Lys48 –linked di-ubiquitin at pH 4.5 (A), at ph 6.8 (B) and of 
K63 –linked di-ubiquitin at pH 6.8 (C). The distal and proximal ubiquitin domains are depicted as 
cartoons in blue and green, respectively. Balls and sticks represent the hydrophobic patch. The side 
residues responsible for the corresponding ubiquitin linkages are shown in red. Structures were 
generated using experimental data of Varadan R. et al. 2005, PDB: 2BGF.  
2.2 The Ubiquitin System 
The posttranslational modification by ubiquitin conjugation is termed as ubiquitination 
or ubiquitilation and is executed step for step by an enzyme cascade35,36 (Figure 4). 
The responsible members of these are belong to three primary enzyme families; 
ubiquitin-activating enzyme (E1), ubiquitin- conjugating protein (E2) and ubiquitin-
protein ligase (E3). Firstly, Ub is activated by a ubiquitin-activating enzyme, which 
uses ATP to form a highenergy, labile E1- thiolester intermediate between the C-
terminal ubiquitin glycine (G76) and its own catalytical cysteine37 . The activated 
ubiquitin is then transferred from E1 to a cysteine residue of an E238 to create a 
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further thiolester intermediate. This activated ubiquitin can now undergo different 
ubiquitination possibilities. It can be passed from E2 to a HECT (homologous to E6-
AP carboxyl terminus) domain containing E3, generate a third thiol ester intermediate 
and then be transferred to a substrate by forming a stable isopeptide bond. The final 
catalyzed isopeptide formation is then between the activated C-terminus of ubiquitin 
and ε-amino groups of internal lysine residues of target proteins39 . The sequential 
addition of further ubiquitin moieties constitutes a polyubiquitin chain. Alternatively, 
the ubiquitination of the activated Ub can be preformed directly from E2 to the Lys 
residue of the substrate which is supplied from the RING finger containing E3s. In 
cases where the polyubiquitin chain is linked through Lys48 of ubiquitin, the 
substrates undergo 26S proteasomal degradation. Nevertheless, beside the ubiquitin 
conjugation on the internal Lys from substrate, the observation of ubiquitin 
conjugation on other substrate internal residues such as Thr, Ser or Cys 40,41,42 is 
remarkable. 
 
 
2.2.1 Ubiquitin Proteasomal System 
The proteasome is a 2.4 mDa multicatalytic central protease complex and 
responsible for the degradation of abnormal and damaged proteins that are labeled 
with K48-polyubiquitin chains (polyubiquitin chains are described in the next section). 
The so-called 26S proteasome complex is comprised of at least 32 different subunits, 
which are arranged in two subcomplexes: two 19S regulatory lid-particles -and one 
20S proteolytic core complex (CP) (Figure 4). The hydrolysis of proteins by 20 CP 
does not require ATP, thus the degradation of ubiquitinated substrates by the 26S 
proteasome is an ATP-independent process43.  
The 19S assembly regulates mainly the capturing and entry of ubiquitinated 
substrates into the 20S proteasome and has no proteolytic activity. Functionally, this 
cap structure contains embedded deubiquitinating enzymes, recognizes K48-
polyubiquitinated proteins, unfolds protein substrates and introduces these into the 
20S proteolytic core44. However, recent studies observed the proteasomal 
degradation of substrates which also are labeled by other polyubiquitin chains45,46. 
Importantly, in order to control cell-cycle regulators, oncogenes, and tumor 
suppressors, correctly folded proteins such as transcription factors or antigens are 
degraded as well47,48. Despite the degradation of proteins labeled by ubiquitin, 
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ubiquitin itself can be degraded by three different 26S proteasomal degradation 
processes. Firstly, the ubiquitin from the most proximal part of the polyubiquitin chain 
is degraded together with its conjugated substrate. Secondly, ubiquitin with a C-
terminal peptide extension longer than 20 amino acids is degraded effectively by the 
26S proteasome. Thirdly, since monomeric ubiquitin has the ability to bind the 
proteasome but does not contain a long enough tail to be delivered into the 20S 
catalytic core, it has to be ubiquitinated also. These kinds of ubiquitination is E3-
independent and specifically performed by an E2 (UBE2K), which catalyses the 
proteasomal degradation of typical Lys48–linked polyubiquitin chains
49. 
 
 
Figure 4. Schematic overview of the ubiquitin-proteasome system. 
During the ubiquitination cascade, ubiquitin is firstly bound and activated by the ubiquitin-activating 
enzyme (E1) via a thiol ester in an ATP–dependent process. The activated ubiquitin is then transferred 
by a trans-thiolation reaction to ubiquitin-conjugating enzymes (E2) that create a second thiol ester 
intermediate. Afterwards, the ubiquitin can be conjugated to the substrate by two strikingly different 
pathways. i) The E2 enzyme interacts with a HECT domain containing E3 ligase and delivers the 
ubiquitin by generating a third homogenous thiol ester intermediate. This E3 enzyme binds its 
substrate and transfers the ubiquitin to the substrate by forming an isopeptide bond between the C-
terminus of ubiquitin and an εNH2 group of an internal Lysine of the substrate. ii) Alternatively, the 
conjugation can be performed directly from E2 to the Lysine residue of the substrate while both are 
bound to a RING domain containing E3 enzyme. In case the polyubiquitin chain was formed through 
the Lys48 of ubiquitin, the ubiquitinated protein is directed to the proteasomal degradation. 
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2.2.2 The Roles of ubiquitination in proteasome-independent pathways  
Despite the involvement in degradation, ubiquitination is also implicated in various 
pathways depending on the respective topology of polyubiquitin chains.  
In addition to the effects described before, the modification of proteins with ubiquitin 
can influence transcriptional activity47,50 and may regulate the sorting into 
lysosomes51 as well. Moreover, monoubiquitin and Lys63-linked di-ubiquitin chains 
can trigger the regulated endocytosis of plasma membrane proteins into primary 
endocytic vesicles52 or into multivesicular bodies (MVBs)53. Furthermore, the 
internalization of receptor tyrosine kinases (RTKs) and G-protein coupled receptors 
(GPCRs) towards the endosomal compartment has been observed and validated54. 
The involvement of monoubiquitination was also described for the assembling of 
vesicels with opposite direction to that during endocytosis, as known for virus 
budding55. These are definitely not the final ubiquitin functions of this wide spread 
and multilateral posttranslational modification and it remains to be seen if further 
sophisticated analysis methods shed light on more cellular functions.  
 
2.3 Ubiquitin like proteins 
Beside the ubiquitin introduced above, various ubiquitin like proteins (UBL) that form 
9 phylogenetically distinct classes (NEDD8, ISG15, SUMO, FAT10, FUB1, Atg8, 
Atg12, Urm1, and UFM1) and share the characteristic three-dimensional fold have 
been discovered. Concerning the conjugation to a target protein, these Ubls are 
conjugated by the same enzyme cascade which is described below for ubiquitin, and 
are covalently attached through the c–terminal glycine to the selected substrate. To 
represent the diversity of these UBLs, the four best-studied ubiquitin like modifiers 
are introduced shortly and summarized with remaining UBLs in Table 1. 
 
 
2.3.1 NEDD8 
The neural cell-expressed developmentally down regulated (NEDD8) genes was 
shown to share 60 % sequence similarity with ubiquitin 56. Analog to ubiquitin, 
NEDD8 is expressed as a precursor that is processed at the conserved c-terminal 
Gly76 by deneddylating enzymes such as Senp8. Mass spectrometry analysis 
recently demonstrated that Lys11, Lys22, Lys48 and Lys60 residues of NEDD8 can 
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be used to form poly-NEDD8-chains57. Interestingly, the conjugation to already 
existing polyubiquitin chains is also possible but their function is unknown58. 
 
2.3.2 ISG15 
The first identified member of the UBL-family was the Interferon stimulated gene 15 
(ISG15), which is also known as Ubiquitin Cross-Reactive Protein (UCRP)59. The 
expression of ISG15 is mainly induced by type I interferon (IFN-α and IFB-β) together 
with viral and bacterial infections60,61. In comparison to ubiquitin there is no evidence 
for a role in the proteasome degradation system61 . Instead, because of the type I 
interferon inducible expression of ISG15 and its conjugation to cellular proteins 
during viral and bacterial infections, it was implicated to play an important role in the 
immune response.  
 
2.3.3 SUMO 
One of the best-studied UBLs is the Small-Ubiquitin-related Modifier (SUMO). 
Mammalian cells express four major SUMO paralogues (SUMO1,2,3,4), however, 
only the first three forms can be covalently conjugated to the target protein. These 
paralogues are classified in subgroups as SUMO-1 and SUMO-2/3 because of the 
sequence similarity of 95% between SUMO-2 and SUMO-3, in comparison to SUMO-
1 (45%). Those two families differ in their cellular concentration, cellular localization 
and their ability to modify distinct proteins62. In recent years more than 1000 proteins 
have been identified as SUMO conjugation targets (SUMOylation)63 and have been 
implicated in transcription, DNA-replication, cell cycling, intracellular transport and  
DNA repair64. 
 
2.3.4 FAT10 
Another ubiquitin like protein is the TNF-alpha-inducible human leukocyte antigen F-
Adjacent-Transcript 10 (FAT10). FAT10 is composed of two consecutive ubiquitin-
related domains and possesses a C-terminal di-glycine motif which is required for the 
conjugation to proteins. The functional role of FAT10 is still not fully understood but it 
was shown to have the ability to act as a proteasomal degradation signal65 and to be 
up-regulated in activated dendritic cells and several epithelial tumors66. 
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Although Ub and Ubl share structural and biochemical properties, this study will focus 
on the well-studied ubiquitin. 
 
 
Table 1. Ubiquitin-like Modifier and their functions 
Ubiquitin-like 
protein 
Sequence 
coverage to 
ubiquitin (%) 
Function 
NEDD8 (Rub1) 60 Positive regulation of E3s 
ISG15/UCRP 29, 37 Immune response, interferone signal transduction, 
potentiall involved in cell growth and differentiation 
FUB1 37 T-cell activation, negative regulator of proliferation 
FAT10 (2 
ubiquitins) 
29 Apoptosis, cell cycle 
UBL5 22 Pre-mRNA splicing 
SUMO1 (Smt3) 18 Control of protein stabilization, Transiption 
regulation, neclear localizationcr 
ATG12 17 Autophagy, cytoplasm - vacuole targeting 
SUMO-2 / 
SUMO-3 
16 Cell cycle progression, Transiption regulation, 
mitosis 
URM1 12 Oxidative stress response 
ATG8 10 Autophagy, cytoplasm - vacuole targeting 
(Modified and extended from Herrmann et al., 2007) 
 
 
 
2.4 Deubiquitinating Enzymes 
Deubiquitinating enzymes (DUBs) are isopeptidases and remove ubiquitin moieties 
from conjugated substrates and they play regulatory roles in a variety of cellular 
processes such as trafficking, endocytosis and in various signaling pathways67. 
Alterations in these processes contribute to disease pathologies such as Parkinson’s 
disease68, autoimmune diseases69 and cancer70. Deubiquitination might be highly 
regulated and functional as important as ubiquitination but is more poorly understood 
than ubiquitination. 
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Humans encodes approximately 95 putative DUBs that have been predicted by 
bioinfotrmatic studies to date, whereas five of these are probably missing the 
transcription67. These proteases have different overall structures, myriad of distinct 
mechanisms and a low sequence similarity, but the overall arrangement of the 
catalytic triad is conserved. Nevertheless, DUBs can be divided in five subclasses, 
classified by their internal domains and the sequence similarity, while four families 
belong to papain-like cysteine proteases and one to zinc-dependent 
metalloprotease71. These subfamilies can be separated in to 58 Ubiquitin-Specific 
Proteases (USP), 4 Ubiquitin C-terminal Hydrolases (UCH), 5 Machado-Josephin 
Disease domain containing proteases (MJD), 14 Ovarian Tumor domain containing 
DUBs (OTU) and 14 metalloenzyme domain containing DUBs (JAMM). 
 
2.5 DUB Function 
The investigations of DUBs function have demonstrated their implication in different 
cellular key processes and their importance will be still continuously discovered. The 
best studied function of DUBs is the generation of free mono ubiquitin by processing 
the ubiquitin-linear-fusion product consisting of multiple ubiquitins, the ribosomally 
synthesized ubiquitin precursors or cytoplasmatic polyubiquitin chains (Figure 5a,e). 
Another well characterized role is the deubiquitination process of K48- linked 
polyubiquitin chains, to rescue the ubiquitinated proteins form proteasomal 
degradation (Figure 5b). DUBs act not only beyond the 26S proteasom machinery 
but also integrat into the proteasome complex itself and couples protein 
deubiquitination, unfolding and translocation into the proteasom. POH1(Rpn11) has 
emerged as the main functional DUB in the proteasome complex, attributed to its 
deletion which cause lethality72,73,74. To maintain the homeostasis of free ubiquitin, 
DUBs recycle ubiquitin by preventing the 26S proteasomal degradation of ubiquitin 
itself (Figure 5d). More recent studies have demonstrated that DUB is involved in the 
removal of non degradative ubiquitin signals (Figure 5c). Such observations were 
done in the regulation of transcription75, intracellular trafficking and sorting of 
proteins76. Alternatively, the contribution in non degradative pathways can be 
supported by DUBs with editing function, and they trim the ubiquitin chain and 
generate another signal at the same time (e.g. trimming from poly- to di-ubiquitin) 
(Figure 5f). Furthermore, due to the fact that branched and forked polyubiquitin 
chains77 exist, the trimming of these chains could generate an exclusively ubiquitin 
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signal. However, high throughput protein-protein interaction experiments suggest 
other potential roles for DUBs including synapse function78 and further signaling 
cascades79.  
 
 
Figure 5. Functions of Deubiquitinating enzymes. 
Deubiquitinating enzymes are indicated with red- and ubiquitin with blue balls. DUBs generate free 
mono ubiquitin by processing the ribosomally synthesized ubiquitin precursors (a) or by disassembling 
of unanchored polyubiquitin chains (b & d). One important task is the removing of ubiquitin from 
ubiquitinated proteins and rescue these preoteins from the proteasomal degradation (c). Alternatively, 
DUBs are involved in non degradation pathways by removing distinct ubiquitin signals or edit certain 
polyubiquitin chains. The Scheme is adapted from Komander, et al. 2009. 
 
To conclude, we have just began to scratch on the surface to understand the 
biological function of DUBs, which is increasing daily with every publication. To 
highlight the importance of this enzyme class, some selected DUBs functions are 
briefly summarized below (Table 2). 
 
 
 
 
a
b
c
d
e
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Table 2. Survey of deubiquitinating enzymes and their associated biological 
functions.  
DUB Biological functions References 
USP8, AMSH, USP9X Endocytosis 80,81, 82 
UCHL1, UCHL3, USP5 Ubiquitin processing 83, 84, 85 
USP7, USP6, USP28 Cell proliferation  86, 87, 88 
USP1, USP3, USP28 DNA damage response 89, 90, 91 
USP14, USP15, PSMD14 Proteasomal degradation 92,93, 94 
CYLD NF-kB signaling 95 
USP11, USP15 Regulation of substrate 
degradation during viral 
replication 
96, 97 
 
 
 
 
2.6 Regulation of Deubiquitinating Enzymes 
The activity of DUBs is carefully controlled to prevent an inappropriate ubiquitin 
processing, which is also represented by their low abundance. Thus the enzyme 
activity is not always present directly after the translocation. For some DUBs, such as 
UCHs and USPs, it could be shown that their catalytic triad adopt the active 
conformation while binding to ubiquitin67, thereby avoiding  the false protease activity. 
The active conformation can be achieved in different ways, for example by shifting 
the occlusion loops from the active site, by active site domain motion or by 
rearrangement of catalytic residues (Figure 6). Another level of controlling is the 
appropriate cellular localization. Good examples are USP14, UCH37 and POH1, 
which achieve their activity after binding to the proteasome98,99. DUB activity can also 
be regulated by transcription, whose transcription is rapidly induced or rapidly 
degraded as an answer to certain cellular processes100. 
 Most proteins are regulated by phosphorylation, ubiquitination or ubiquitin like 
modifications and DUBs are not an exception. Thereby recent phosphorylation 
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examples are USP15, USP19, USP28 and USP34, which were phosphorylated by 
ATR/ATM in response to DNA damage101. The ubiquitination of DUBs may directly 
enhances the activity of deubiquitinating enzymes and was recently reported for 
Ataxin-3102. Otherwise, it could be shown that the sumolation of USP25 inhibits its 
activity103.  
 
 
Figure 6. DUBs regulation upon conformational changes. 
A) The accessibility of the active site is regulated by occluding loops which must be displaced to allow 
the substrate binding. B) The active site is occupied by certain domains which must be displaced for 
an appropriate substrate binding. C) The substrate binding cause a conformational change which 
reorients the catalytic residues and therefore allow an active processing (F. Reyes-Turcu et al. 2009) 
 
2.7 DUB Specificity 
DUBs specificity can be displayed at multiple levels and may be referred to as the 
specificity towards different ubqiuitin linkages or to the ubiquitinated proteins. The 
different DUB specificity layers are summarized in Figure 7 and described below. The 
polyubiquitin chains differ in their topology and the sequence context around the 
isopeptide bond between two ubiquitin moieties. These features contribute to DUB 
cleavage specificity and are not restricted to a certain DUB family. The disassembly 
of polyubiquitin chains can be carried out from the chain ends (exo) or may started 
directly within a chain (endo). Comparing to exo-DUBs, the endo-DUBs recognize 
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larger surface patches of two Ub moieties and cover thereby more the polyubiquitin 
specified DUBs. Deubiquitinating enzymes can also recognize and bind directly to the 
ubqiuitinated target protein. For instance, these DUBs are able to cleave off the 
whole polyubiquitin chain, rescue the protein from degradation or amputate the Ub 
chain till monoubiquitin, which gives the possibility to build up a new Ub chain. More 
target specific DUBs may be those whose specifically recognize a monoubiquitinated 
substrate and remove Ub from mono- or multiple sites. Last but not least, the mono 
ubiquitin pool will be mostly generated from DUBs whose process just unanchored 
polyubiquitin chains or ubiquitin with small remained tails. This kind of processing is 
mostly carried out by DUBs from the UCH family. 
 
 
 
Figure 7. DUB specificity at multiple levels. a) DUBs which recognize and process distinct ubiquitin 
linkages. b) DUBs with the preference to disassemble the polyubiquitin chains from the ends (exo) or 
starting to cleave directly within the ubiquitin chain. c) DUBs with certain substrate specificity which are 
able to amputate directly the whole ubiquitin chain (right scheme) or remove ubiquitin moieties in one 
step till monoubiquitination. d) DUBs with substrate specificity which recognize the protein and remove 
the mono- or multi-ubiquitin. e) DUBs which are specialized to remove small peptide fragments (< 8 
AA) from the C-terminus 
of ubiquitin, such as products after the proteasomel degradation (Komander, et al. 2009). 
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2.7.1 Enzymatic reaction mechanism of DUBs 
Although DUBs display distinct substrate specificities and are involved in different 
functional roles, the important regulatory mechanism within the cysteine proteases 
and metalloproteases show certain similarities.  
The papain-like cysteine protease DUB subclasses (USP, UCHs, OTUs and MJDs) 
rely on the catalytic conserved diad (cysteine (Cys) and histidine (His)) or constituting 
a triad through additional amino acids such as asparagine (Asn), aspartate (Asp), 
glutamine (Gln) or glutamate (Glu). Remarkably, all cysteine protease derived DUBs 
present divergent structural folds, but superpose only small differences in catalytic 
rearrangement after binding the C-terminus of ubiquitin.  
The catalytic mechanism of these subclasses will be briefly described below.  
Within the catalytical triad the thiol group of cysteine is deprotonated by an 
neighbouring histidine which itself is polarized by asparagine or aspartate, although 
this is not always essential for activity104. The final deprotonation is accomplished 
during the nucleophilic attack of cysteines thiol group onto the crucial peptide linkage 
bond (Figure 8). In terms of DUBs this reaction occurs at the Ub-linkage dependent 
isopeptide bond, consisting through the covalent bond the carboxy-terminal glycine of 
one ubiquitin to an internal lysine of another. 
In terms of DUBs this reaction occurs at the isopeptide bond, consisting of the 
covalent bond of the carboxy-terminal glycine of one ubiquitin and an internal lysine 
of another ubiquitin or substrate. The thiol-ester intermediate consisting of Ub-
carboxy-terminus and the cysteine thiol, is stabilized in the “oxyanion hole”, which is 
spatial composed above catalytic backbone of the cysteine and the residues Gln, Glu 
or Asn. The next catalytic steps are performed through the formation of an acyl-
enzyme intermediate, generation of the second tetrahedral intermediate and its 
hydrolysis via a water molecule. Finally, the ubiquitin carboxylic acid product diffuse 
from the active site and the catalytical triad rearranges for the next cleaving process. 
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Figure 8. Schematic reaction mechanism of substrate hydrolysis by papain-like cysteine proteases. a) 
FORMATION OF ES COMPLEX:The active site Cys-SH is activated by His (imidazole ring N: ) in 
catalytic triad. Afterwards Cys-S becomes a reactive nucleophile and undergo a nucleophilic attack on 
carbonyl C of substrate and forms a covalent bond. b) TRANSITION STATE STABILIZATION by 
movement of substrate oxyanion of intermediate into the oxyanion hole. c) FORMATION OF ACYL-
ENZYME INTERMEDIATE: The amide bond breaks and that amine product (RNH2) dissociates.The 
oxyanion is accomplished back into C=O by forming the acyl-enzyme-intermediate which represents a 
covalent ester linkage.d) FORMATION OF THE SECOND TETRAHEDRAL INTERMEDIATE: His 
activates the O from the water molecule (H2O), makes it nucleophile potent which than attack the 
carbonyl C of acyl-enzyme intermediate. e) DISSOCIATION OF SUBSTRATE:The ester bond cleaves 
and generate the carboxylic acid component (R'COOH) which than dissociates from the active site. 
 
 
In contrast to cysteine proteases, metalloproteases generally coordinate a metal ion 
(Zn2+) with two His and an Asp in order to polarize a water molecule and create a 
noncovalent intermediate of substrate/enzyme intermediate. Further residues such as 
Glu and Ser contribute to the coordination of the water molecule and the substrate. 
After the substrate was conformational detected, the spatial orientation towards the 
catalytic site is coordinated by Ser, Asp and Glu while a water molecule is activated 
by a zinc ion. Similar to the reaction mechanism described for cysteine proteases 
above, the “activated” water molecule undergoes a nucleophilic attack on carboxylate 
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of the isopeptide bond (Figure 9a) and generate the tetrahedral intermediate. Just 
before the proteolytic step occurs, the glutamic acid serves as a proton acceptor 
(Figure 9b) and transfer than the proton to the amide nitrogen which is followed by 
tetrahedral intermediate collapse and causing the substrate release (Figure 9c)105.  
The following section will introduce the five individual DUB subclasses.  
 
 
 
Figure 9. Schematic representation of the catalytic mechanism of metalloproteases derived from the 
structure of AMSH-LP bound to diubiquitin
106
. Distal ubiquitin is labeled in blue, the proximal ubiqiutin 
highlighted in pink and Zn coordinated water is depicted in red. a) Nucleophilic attack of water 
molecule on the carbonyl carbon of the isopeptide bond. b) Glu 292 conduce as proton acceptor and 
is in the final step c) -responsible for the intermediate collapse by transferring the proton on the amide 
nitrogen from the distal ubiquitin, (modified  from Urbé et al., 2009). 
 
2.7.2 Five Subclasses of Deubiquitinating Enzymes 
In spite of the paucity of the knowledge concerning the DUB specificity, some of the 
structures and internal domains are investigated and display various features. 
Despite these large presented differences all cysteine protease DUB families (UCHs, 
USPs, OTUs and MJDs) belong to papain-like cysteine proteases and rely on a 
catalytic diad or triad30. In contrast to cysteine proteases, metalloproteases (JAMMs) 
uses a metal ion oriented water molecule which acts as a nucleophile and enables 
the catalytic reaction105. To further shed light on the important differences, the 
subclasses will be briefly introduced separately. 
2.7.3 Ubiquitin carboxy-terminal hydrolases (UCHs) 
The human encodes four UCH domain containing DUBs with highly conserved 230 
amino acids catalytic domoain (Reyes-Turcu et al., 2009). Those were discovered as 
enzymes which preferentially cleave newly synthesized polyubiquitin precursors or 
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ubiquitin fused to ribosomal protein precursors. This process can be carried out 
cotranslationally107 and represents the extreme fast catalytically activity of these 
enzymes. It was long believed that these enzymes hydrolyze only small fragments 
from the C-terminus of ubiquitin which attributes to a plugging loop directly in the 
catalytic groove. However, recent structural analysis show that the ubiquitin binding 
orients the misaligned active site into productive conformation108 and thus explains 
the observed disassemble ability of polyubiquitin chains and ubiquitin-conjugates67,15.  
 
 
2.7.4 Ubiquitin – Specific Proteases (USPs) 
The USP family is the largest and most diverse subclass of DUBs and is represented 
with more than 50 USPs. These cysteine proteases poses a conserved catalytic 
motif, the Cys box and the His box, but the size of the domains varies from 300 to 
800 AAs. Structural analysis showed that the sequence similarity is low but the USP 
domain fold is highly conserved15 and is constellated of three sub-domains termed 
finger, palm and thumb109. The USP sequences also contain several specificity 
dependent domains like, ubiquitin binding domains (UBDs), ubiquitin interacting 
motifs (UIMs), different zinc finger (ZnF) motifs and various enormously in their size. 
Not surprisingly, the cleavage activity of USPs is involved in several cellular key 
processes (e.g. signal transduction110, endocytosis111 and DNA repair27) and thus is not 
restricted for one specific Ub-constelation or Ub-linkage type112,15.  
 
 
2.7.5 Machado-Joseph Disease (MJDs) Protein Domain Proteases  
Applying bioinformatic approaches, Ataxin 3 was the first identified member of MJD 
proteases and is the best studied one. The name derived from a gene mutation 
which results in a spinocerebellar ataxia type-3 disease or also known as Machado-
Joseph Disease15. The sequence similarity to other classes is low but the overall fold 
is similar to UCH DUBs. Recently, Stephen Weeks and his colleges solved the first 
crystal structure113 for a Josephin-substrate complex and Brett Winborn showed the 
specificity of Ataxin 3 towards K63- linked ubiquitin chains
113. However, both the 
biological function as well as Ub-linkage preference of the other class members still 
have not been discovered67.  
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2.7.6 3.7.4. The JAMM Motif Metalloproteases  
The JAMM subclass is represented by 14 metalloproteases which contain the 
conserved Zn2+ ion stabilization assemble. This motif coordinates two zinc ions for 
the activation of a watermolecule which then attack the internal isopeptide bond 
within the ubiquitin linkage. To note are the seven JAMM members which have at 
least one amino acid exchange in the catalytically Zn motif and thus are most likely 
not deubiquitinating enzymes67 Interestingly, most of the JAMM DUBs were 
commonly found within large complexes, for instance POH1 (Rpn11) in the core 
structural component of the 19S proteasome complex114 or AMSH as an associated 
DUB in the ESCRT machinery (also known as STAMBP)115. The crystal structure of 
AMSH-LP bound to K63- linked di-ubiquitin revealed for the first time the mechanism 
for the preference of JAMM DUBs towards K63 linked ubiquitin chains
106. 
JAMM members exhibits different functions and were described to precipitate for 
instance in vesicle trafficking106, in DNA repair116 or in endocytosis117. 
 
2.7.7 Ovarian Tumor Proteases (OTUs) 
The first Ovarian Tumor (OTU) family members were discovered by bioinformatics 
homology118 with the ovarian tumor genes which regulate the translation of RNA 
transcripts119.  
The OTU subclass members serve the OTU domain and contain the typical cysteine 
protease catalytic triad formed of His, Cys and Asn/Asp. One interesting member is 
A20, that contains the OTU as well the as the zinc finger domain and can act as an 
ubiquitin-protein ligase69 as well. Furthermore, the multifunctional aspect was shown 
by OTUB1 which is able to interact with an enteropathogen Yersinia encoded 
virulence factor120, and is assembled in a complex encompassed by USP8 and 
GRAIL121. However, the functional role of further members remains to be 
investigated.  
 
2.8 Active site directed probes 
Various sequencing efforts and proteomics approaches, such as analysis of protein 
expression level and protein modification by LC-MS, have shed light on the 
proteome. However, their detection does not directly imply the functional state of the 
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protein, whose activity often relies on post-translational modifications or subcellular 
localization. To address this issue, a powerful technique termed activity-based 
protein profiling (ABPP) can be applied to analyze the protein expression and directly 
their function in complex proteome mixtures (Figure 11). ABPP utilizes chemical- and 
protein-based probes, also called as active-site directed probes (ABP). These probes 
are designed to address the substrate specificity of certain target enzymes and are 
able to bind covalently a subset of proteome with similar catalytically features. 
Several enzyme classes, such as proteases, kinases and phosphotases have been 
characterized by utilizing ABPs122. The generation of high potential ABPs has 
emerged either through the knowledge of enzymes or by careful selection of 
irreversible and reversible inhibitors123.  The constellation of ABPs is based on three 
components (Figure 10): (i) a chemical reactive group (trap) which is designed to 
interact covalently with the catalytic residues of the enzyme of choice, (ii) a binding 
group which is responsible for the specific interaction with the target enzyme, (iii) and 
an analytical tag.  
 
 
Figure 10. Building blocks of an ubiquitin derived activity-based probe (ABP). 
A) The general constellation of ubiquitin derived probe, consisting of a reactive chemical group (trap), 
ubiquitin as the specificity unit and the tag for detection, immunoprecipitation and visualization 
purposes. B) Deubiquitination of ubiquitin conjugated proteins. The catalytic active cysteine residue of 
DUBs performs a nucleophilic attack on the isopeptide bond of the C-terminus of ubiquitin and the 
lysine of the substrate.  
 
The internal trap, such as an epoxide or Michael acceptor, is designed to address the 
catalytic chemistry of enzymes. The reactivity of probe towards the enzyme (DUB) 
active-site depends partially also on chemical properties of the traps, including their 
affinity and native chemical reactivity. The fine-tuning of probes in respect to the 
variation of traps provides a suitable handle to control their enzyme selectivity.  
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The integration of specific elements, e.g. ubiquitin in this study, alters the probe from 
their broad reactivity to more selective labeling of enzymes. 
The possibility to vary the tag; for instance in a suitable fluorescence or FRET based 
tag would allow the monitoring of active-enzyme formation in a more real-time way. 
Nevertheless, the choice of tag type should be considered accurately to avoid the 
negative interference with other probe elements, such specificity unit or the trap. To 
address this challenge, good performance was observed by using click chemistry 
based probes124,125. A further possibility is the introduction of a “delivering element”, 
for example a cell penetrating peptide, which targets the probe to a certain cell type 
and also enables in vivo experiments. The design of DUB specific probes was 
pioneered by development of intein-based protein-expression systems126, which 
enables the modification of the C-terminus of Ubiquitin with a additional chemical 
reactive group127. The ubiquitin-vinylmethylester probe (HAUB-VME) is a well studied 
and promising active-site directed probe with broad reactivity towards DUBs128. This 
probe binds covalently to the active-site (Cys) of DUBs, with the exception of the few 
metalloproteases. The N-terminal epitope tag hemagglutinin (HA tag, YPYDVPDYA) 
of ABPs helps to detect the modified DUBs after the separation of a protein mixture 
by SDS-PAGE or immunoprecipitation, followed by immunobloting or mass 
spectrometry analysis (Figure 11). The wide range of possibilities to design the 
probes are very promising for the development of powerful tools which would allow to 
characterization of enzymes in their biological environment in more detail. 
 
 
Figure 11. Workflow of activity-based protein profiling (ABPP).  
Target proteins of the complex proteome mixture are modified (labeled) with activity-based probes. 
Shown are two possible ABBP workflows:  (i) Gel-based activity-based protein profiling and (ii) 
enriched by affinity purification, followed by identified using mass spectrometry. 
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3 Materials and Methods 
All Chemicals and organic solvents used were reagent and HPLC grade, 
respectively. The materials were purchased from Sigma-Aldrich (Taufkirchen, 
Germany) unless indicated otherwise.  
 
Table 3. Material and reagents supplied from distinct companies.  
Material Company 
1,4-Dithiothreitol ≥99% (DTT)  Serva  
Amersham ECL+ Western Blotting Detection 
Reagent 
GE Healthcare 
Ammoniumphosphat (APS)  Serva  
Benzonase  Merck  
Complete Protease Inhibitor Cocktail  Roche  
Coomassie Brillant Blue G250  Serva  
EDTA  Merck  
HEPES Pufferan® ≥99.5%  Roth  
Glycin ≥99% p.A.  Roth  
Glycerin ~86% p.A.  Roth  
LiChroprep RP-18  Merck  
Natrium-Chlorid ≥99.5% p.A. (NaCl)  Roth  
Rotiphorese® Gel 30 (37.5:1)  Roth  
TEMED 99% p.A.  Roth  
Triethylammonium Bicarbonat Puffer p.A. for 
HPLC (TEAB)  
Fluka  
Trifluor-Essigsäure ≥99.5% (TFA)  Fluka  
Material Company 
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Tween® 20  
Zip-Tip-C18μ 
Roth  
Millipore 
Chitin Beads (S6651L) BioLabs 
 
 
3.1 Peptides 
Peptides were kindly provided by the Dept. Chemical Biology and analyzed by RP-
HPLC (Agilent 1200 Infinity HPLC, column: Phenomenex Gemini 50 × 2mm, C18, 
3µm, 110Å; gradient: 5–95% 0.1% TFA/acetonitrile in 0.1% TFA/water in 7 min, flow 
rate: 0.4 mL min−1, detection: 214 nm) with online ESI-mass spectrometry detection 
(Applied Biosystems API2000 triple quadrupole MS).  
 
3.2 Antibodies 
The following antibodies were used in this study:  
Table 4.  Antibodies used in this study. 
 AB species  Dilution Company 
α-HA Mouse, 
monoclonal 
1:1000 Roche, Switzerland,  
α-HIS Mouse, 
monoclonal 
1:2000 Merck, Germany 
α-mouse 
IgG+IgM 
Goat 1:3000 Jackson 
ImmunoResearch  
α-HA 
agarosa 
beds 
Mouse, 
monoclnal 
50-100  
µl suspension 
Sigma-Aldrich, Germany 
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3.3 Cell lines and culture conditions 
All cells (Table 5) were cultured at 37°C and 7.5% stable carbon dioxide (CO2) using 
Innova (Germany) incubators.  
 
Table 5. Cell lines and culture conditions used in this study.  
Cell Line Origin Culter Conditions 
EL-4 mouse, lymphoma Dulbecco's modified Eagle's Medium 
(DMEM), 10% FBS, 1X Pen/Strep, 
2mM glutamine 
Jurkat  
E6-1 
human,T cell leukemia RPMI1640, 10% FBS, 1X Pen/Strep, 
2mM glutamine 
HeLa S3 human, cervix, adenocarcinoma DMEM, 10% FBS, 1X Pen/Strep, 2mM 
glutamine 
MCF-7 human, breast-adenocarcinoma Modified Eagle's Medium (MEM-α), 10 
% FBS, 1X Pen/Strep, 2mM 
glutamine, 10 µg/ml of bovine insulin 
A549 adenocarcinomic human alveolar basal 
epithelial 
F-12K, 10% FBS, 1X Pen/Strep, 2mM 
glutamine 
 
 
3.4 Fermenter parameters 
The following fermenter parameters were used for the Fermenter Labfors 5L in this 
study: 
 
 Composition Amount   
Selection 
factor 
Ampicillin, chloramphenicol     
Run time 24h    
Medium: Tryptone 60g 4.5L 5L 
 Glycerin 20ml 
 Yeast Extract 120g 
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Composition Amount 
 
 add after autoclaving (10 min 121°C):  
 KH2PO4  11.5g 0.5L 
 K2HPO4 62.7g 
Harvesting 5L by centrifuge 15 min at 6000 x g (4°C)     
 
 
3.5 Protein expression in E. coli 
The HA-Ub-intein-chitin fusion construct was expressed in BL-21star E. coli. For this 
purpose 15 ml LB-medium containing 100µl/ml chloramphenicol (cmp) and ampicillin 
(amp) were inoculated with the glycerol stock E. coli cells containing the “pTyb2-
HAUb” plasmid. The culture was incubated over night at 180 rpm and 37 °C in a 
Multitron (INFROS HT) incubator. Following, the 15 ml culture was transferred to a 2L 
shaking flask with 500ml LB-medium (cmp/amp) and incubated by shaking at 130 
rpm and 37 °C for 1-3 h, until the optical density (OD) value of 0.9-1.0. The protein 
expression was induced by 0.5 mM IPTG and the continued culturing at 180 rpm, 20 
°C over night. After the cultivation the cells were pelletized at 3500 x g. 
 
 
3.6 Buffer and reagents used in this study 
 
Buffer Composition Concentration 
Lysis buffer (pH 7.5) 4-(2-hydroxyethyl)-1-
piperazineethanesulfonic 
acid (HEPES) 
50 mM 
sucrose 250 mM  
MgCl2 50mM 
IGEPAL 1% (v/v) 
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Buffer Composition Concentration 
 
4x sample buffer N-tris(hydroxymethyl)-
methylglycine (Tris) pH 6.8 
25mM 
SDS 8% (w/v) 
dithiothreitol (DTT) 3 mM 
glycerol 80% (v/v) 
bromphenol blue 0.02% (v/v) 
 
NET-buffer (pH 7.5) TRIS 50 mM 
NaCl 150 mM 
ethylenediaminetetraacetic 
acid (EDTA) 
5 mM 
IGEPAL 0.5% (v/v) 
 
RP buffer A TFA 0.1% (v/v) in MQ 
 
RP buffer B TFA 0.1% (v/v) in MQ 
acetonitrile (ACN) 60% (v/v) in MQ 
 
 
DUB-reaction-buffer 
(pH8.0) 
TRIS 50 mM 
NaCl 50 mM 
DTT 1 mM 
ATP 1mM 
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Buffer Composition Concentration 
 
Buffer-CIEX A (pH 4.5) HEPES 10 mM 
 
Buffer-CIEX B (pH 4.5 HEPES 10 mM 
NaCl 1M 
 
1xSDS running buffer TRIS 24 mM 
glycine 199 mM 
SDS 0.2% (v/v) 
 
Gel fixing solution EtOH 30% /v/v) 
Acetic acid 10% (v/v) 
 
Coomassie Silver 
(according to Candiano) 
H3PO4 (85%) 10% (v/v) 
 (NH4)2SO4 10% (w/v) 
 MeOH 20% (v/v) 
 Coomassie BB-G250 0.12% (w/v) 
 
10x Blot buffer TRIS, pH 8.3 (HCl) 0.25 M 
 Glycine 1.92 M 
 SDS 35 mM 
 
1x Blot buffe 10x Blot buffe 10% (v/v) 
 MeOH 20% (v/v) 
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Buffer Composition Concentration 
 
PBS (pH 7.4) NaCl 137 mM 
 KCl 2.7mM 
 Na2HPO4 10mM 
 KH2PO4 2mM 
LB-Medium 
autoclaved at 121 °C 
Luria Broth powder 
MiliQ 
15 g 
600 ml 
 amp(x 1000; 100 mg/ml) 5ooµl 
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3.7 Intein-based chemical ligation 
3.7.1 Synthesis of HAUb75 – MESNa thioester 
In order to get the starting material HAUb75, the HA-Ub-intein-chitin fusion construct 
(containing the chitin binding domain, CBD) was expressed in BL-21star E. coli and 
induced with 0.5 mM IPTG at 20°C O/N using 2L shaking flask or fermented in 2 or 
5L Labfors (Swizerland) fermenter. 
Detailed information according fermenter parameters are supplied in the supplement 
section.  For harvesting, cells were pelleted at 3000 x g, resuspended in 100ml lysis 
buffer (+ protease inhibitor cocktail (Roche), 4°C) and homogenized by one French 
press passage at 20000 psi followed by sonication for 10min at 4°C. The suspension 
was then clarified at 36000 x g (RC6 centrifuge, Thermo Fisher Scientific, USA) for 
30 min and the supernatant filtered with 0.45 µm nylon (NY) membrane filter 
(Millipore, France).  
The clarified cell lysate was then transferred to glass columns containing 10-15ml 
chitin beads (New England Biolabs, UK), which were previously washed with 100ml 
cold lysis buffer. In order to allow the Ub-intein-chitin fusion construct to bind to the 
chitin beads, the suspension (cell lysate/chitin beads) was incubated for 5h at 4°C 
with gentle shaking. Afterwards, to get rid of unbound proteins, the beads were 
washed with lysis buffer. Subsequently, 15ml of lysis buffer containing 50mM MesNa 
was passed though the beads and then refilled again till all beads were covered. The 
on-column cleavage, to gain the HAUb75 – MESNa thioester product (Figure 12), was 
induced with an overnight incubation at 37°C. After incubation the flow-through 
containing the desired HAUb75 – MESNa thioester product was collected followed by 
an additional rinsing step with 10ml lysis buffer to get the remaining product.  
In contrast to the previously published methods the HA-Ub75 – MESNa thioester was 
purified to get rid of MESNa, which undergoes a competition reaction with thiol-
reactive groups in the conjugation step. In order to perform the purification, the 
product was filtered with 2 µm NY filter (Millipore, France) and concentrated (~ 10ml) 
while exchanging the buffer to 50mM NaOAc, pH 4.5 using VIVASPIN-20 5000 
MWCO (Sartorius Stedim Biotech GmbH, Germany) at 3000 x g and 15°C. 
The purification was performed with cation exchange (CIEX) chromatography using 
the ÄKTApurifier 10 (GE HealthCare) system and a MonoS 10/10 column with a 
linear gradient from 0% buffer-CIEX A to 50% buffer-CIEX B. To avoid hydrolyzing 
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processes, the eluted fractions were immediately analyzed by MALDI-TOF MS. The 
fractions containing the appropriate HAUb75 – MESNa thioester product were pooled 
and desalted via VivaSpin-1 3000 MWCO against 50 mM NaOAc (pH 4.5) to an end 
volume of 0.5 ~1 ml.  
 
3.7.2 Generation of active-site directed probes 
The generation of active site-directed probes is based on the ligation of reactive 
HAUb75 – MESNa thioester with an appropriate C-terminal electrophilic group 
(Figure 12), also termed “warhead”. These warheads were designed and synthesized 
using Horner-Wadsworth-Emmons reaction to predominantly produce the preferred 
E-form of the required glycine-based electrophilic group, more details are provided in 
the supplement 10.2 (in collaboration with Dept. of Chemical Biology, HZI). The 
warheads were then ligated with the recombinantly expressed HAUb lacking the C-
terminal glycine (G76) and carrying a reactive thioester group instead (HAUb75 -
MESNa), as described in the section above (3.7.1).  
 
 
Figure 12. Schematical presentation of the Generation of HAUb derived active site- directed probes 
based on intein chemical ligation. 
The produced amino functionalized thiol reactive groups (warheads) were dissolved 
in 100-200µl, 100mM HEPES by adjusting the pH value finally to pH 8 using 0.1M 
NH4HCO3. Alongside, the ligation step was improved by adding 2M S-NHS as 
biocatalyst to 500µl of HAUb75 –MESNa and adjusted to pH 8 using NaHCO3. Finally, 
Materials and Methods 
[36] 
 
the active HAUb-derived thioester was ligated with the previously produced amino-
functionalized warheads overnight at 37°C.  
After the overnight incubation the probe product was filtered using 0.22µm NY 
membrane (Millipore, France) and the buffer was exchanged via VivaSpin 1ml -3000 
MWCO concentrator. Afterwards, the probes were purified by utilizing the same setup 
as described in section 3.7.1, the appropriate fractions were pooled and concentrated 
by simultaneously exchanging the buffer to 50mM HEPES, pH 7.4 (storage buffer). 
Finally, the concentration was determined by Nanodrop Spectrophotometer 
(PEQLAB, Germany), and the probes were validated and characterized by ESI-Q-
TOF MS / MALDI-TOF MS and stored at -80°C. 
 
3.8 Cell harvesting and storage 
In order to gain the high protein concentration of cell lysates and to get the possibility 
to work reproducibly in the following experiments by parallel handling parallel of 
different cell lines, cell pellets of each cell line were prepared and stored at -80°C. 
Therefore, cells were cultivated until the confluence of 80-100% utilizing 150 mm 
uncoated culter dishes and harvested by placing the dish on ice. 
For this purpose, the medium was discarded, the cells rinsed with ice cold PBS and 
scraped off from dishes. Following this, the cell suspension was directly transferred 
into ice-cold falcon tube. Afterwards the cells were pelleted by 950rpm centrifugation 
and at 4°C for 15 min. In the next step the supernatant was discarded, pellets 
washed two times with PBS and the pellets finally stored at -80°C. 
 
 
 
 
3.9 Cell lysis 
Frozen cells were thawed on ice and transferred into 2ml reaction tubes containing 
300 ml glass beads (rinsed with PBS before use). To start the lysis, 1ml of lysis buffer 
and 250 units/ml benzonase (MERCK) were added. The high-speed vortexing for 40 
min at 4°C supported the lysis with shear forces and was further enhanced by 
additional 10min sonication using an ice cold bath. To get a clear cell lysate, the 
suspension was transferred into a new reaction tube, centrifuged two times for 20min 
Materials and Methods 
[37] 
 
at 18000 x g (4°C) and the clarified lysate finally transferred into a new reaction tube, 
which was stored on ice until usage. 
 
3.10 Determination of protein concentration 
The protein concentration (of cell lysates) was determined according to the Bradford 
assay129. The standard calibration curve was determined by using a dilution series of 
bovine serum albumin (BSA) from 0.1 – 1 mg/ml. All measurements were carried out 
in triplicates and were performed by an Infinite M200 Elisa reader (Tecan, 
Switzerland) at an absorption measurement at 595nm. The concentration 
measurement of ABP products was performed with Nanodrop using water or 
appropriate buffer as reference. 
 
 
 
3.11 Activity based profiling by utilizing HAUB-VFEA probe 
The profiling experiments using HAUb-VFEA were performed with the help of Anne 
Kummer as part of her master thesis. 
The protein concentrations of all cell lysates were adjusted with 50mM HEPES (pH 
8.0) to a final concentration of 9 mg/ml in an end volume of 1 ml. To enable the 
appropriate labeling after the adding of 0.8 µg of HAUb-VFEA, the samples were 
adjusted to a pH value of 7.5-8.0. The incubation of 2h at 37°C allowed HAUb-VFEA 
to react. The reaction was stopped by adding sodium dodecyl sulfate (SDS) to a final 
concentration of 0.3% (v/v) and further incubation of 15min at RT. Afterwards, the 
samples were subjected to an immunoprecipitation for the identification of probe-
labeled enzymes,  
3.11.1 HA-Immunoprecipitation of HAUb-VFEA-enzyme complex 
After the enzyme labeling procedure with HAUb-VFEA (Activity based profiling by 
utilizing HAUb-VFEA probe, described above), the SDS concentration was further 
reduced to the final concentration of 0.1% using NET-buffer. Further on, 100µl of 
monoclonal anti-HA agarose beads (Sigma, clone HA-7) were washed with NET-
buffer, placed into centrifuge columns with Polyethylene filter, ~30µm pore size 
(Thermo Fisher Scientific, USA) and filled with the samples. Afterwards, sealed 
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columns were incubated for 5h at 4°C by continuously rotating at 6 rpm. After the 
incubation the unbounded proteins were discarded by shortly spinning down the 
columns at 200 x g and washed twice with NET-buffer and 0.1M ammonium 
bicarbonate (NH4HCO3). Immunoprecipitated proteins were eluted with 4x sample 
buffer or digested directly on beads. 
 
3.11.2 Tryptic on bead digest 
To enhance the tryptic digest by providing trypsin the direct access to the proteins, 
the digest directly on beads was favored. In order to facilitate the protein 
identification, the proteins have to be reduced and carbamidomethylated. The protein 
reduction was carried out by covering the beads with 20mM DTT (in 0.1M NH4HCO3) 
followed by an incubation of 30min at 56°C. Afterwards the solution was discarded by 
shortly spinning down the column. The carbamidomethylation was achieved by 
addition of 55mM iodacetamide (in 0.1M NH4HCO3) and an incubation of 30min at 
RT in the dark. To get rid of left reagents, the beads were washed by spinning down 
two times with 0.1M NH4HCO3.  
The digestion of precipitated proteins bound on the beads was executed by adding 4 
µg of trypsin (Sequencing grade-Promega) dissolved in 10mM NH4HCO3, followed by 
an overnight incubation at 37°C and gently shaking at 70 rpm. The digested proteins 
were eluted from the beads by shortly spinning down, followed by additional two 
wash steps with 0.1% (v/v) trifluoroacetic acid (TFA, pH 3). To avoid some impurity, 
the samples containing the eluted proteins were centrifuged at 109000 x g for 20 min 
and the supernatant stored at 4°C for further usage.  
Peptide Purification 
Almost all commercially available agarose beads contain the plasticizer polyethylene 
glycol (PEG), which interferes with chromatography columns within mass 
spectrometric methods. To get rid of PEG from the peptide mixture, derived from the 
on-bead tryptic digest, a reverse phase (RP) chromatography approach was applied. 
Therefore, the samples were subjected to an Äkta Purifier system (GE Healthcare, 
Germany) just after the equilibration with 0.1% TFA (buffer A). After the binding of 
peptide on the self-packed C18 column (Merck, Germany) these were eluted with RP 
buffer B (without gradient). Although no gradient was applied, the peptides and PEG 
eluted differently. The fractions containing the corresponding peptides were pooled 
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and dried in a speedvac (vacuum concentrator, Thermo Fisher Scientific, USA). 
Afterwards, these were dissolved in 6% ACN in 0.1% formic acid (FA), sonicated for 
5min and diluted to an end concentration of 3% ACN using 0.1% FA. To ensure the 
purity of the sample, the samples were centrifuged at 109000 x g for 20 min at 4°C 
and transferred into glass vials (Waters, USA) for further mass spectrometric 
analyses.  
 
 
3.12 HA-Immunoprecipitation of UIPP-probe enzymes adducts 
The crude cell lysate, prepared as described above, was diluted to a protein 
concentration of 6.25mg/ml (500µl total volume) using 50mM HEPES, (pH8.0). Then 
0.8 µg of UIPP (Ub42-54 -K48(VA) or Ub54-72 –K63(VA) ) was added and the pH-value 
adjusted to pH 8. As negative control, an aliquot of each cell lysate was treated 
exactly as the sample, however adding HEPES-buffer instead of UIPP. The samples 
were then incubated for 1h at 37°C to allow the probes to react. Afterwards, the 
reaction was stopped by adding SDS up to a final concentration of 0.3% (v/v) and 
incubated for 15 min at RT. Afterwards the cell lysate was further diluted to the final 
SDS-concentration of 0.1% using NET-buffer. To avoid contaminations, 100µl of 
monoclonal anti-HA agarose beads (Sigma, clone HA-7, 1:1 suspension) were 
transfer into spin columns (Thermo Fisher Scientific, USA) and washed with NET 
buffer. To achieve the precipitation of covalently bound probes, the diluted cell lysate-
probe mix was added to the beads and incubated for 1h at 4°C with continuous 
rotation. After the incubation, the flow-through was discarded and the columns 
washed twice with NET-buffer. Finally, 50 µl of 2x reducing sample buffer was added, 
the columns sealed and incubated for 5 min at 97 °C. The probe-enzyme adducts 
were then eluted by spinning down at 200 x g. To assure the elution of all 
precipitated proteins, the beads were covered additionally by 50 µl of 0.1% formic 
acid (FA) and spun down again. The eluted proteins were then resolved with 4-12% 
SDS-PAGE and stained with Coomassie Brilliant Blue. The relevant gel-lanes were 
excised, tryptic digested (In-gel digestion protocol) and analyzed with LC-MS/MS.  
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3.12.1 In-gel digestion 
The excised gel pieces of interest were covered with 20mM DTT in 0.1M NH4HCO3 
and incubated for 30min at 56°C. The solution was then discarded and the pieces 
dehydrated by adding acetonitrile (ACN) followed by 15 min incubation until these 
became white. ACN was exchanged by covering them with 55mM iodoacetamide in 
0.1M NH4HCO3 followed by incubation for 30min at RT in the dark. Afterwards the 
solution was discarded, followed by dehydrating with ACN and drying the gel pieces 
using speedvac (Thermo Fisher Scientific). Subsequently, the gel pieces were 
washed twice with 0.1M NH4HCO3. For the tryptic digestion, the gel pieces were 
covered with 1µg trypsin (Promega Gold Standard), dissolved in 10mM NH4HCO3 
and incubated overnight at 37°C. The resulting peptides were extracted by adding 
the same volume of ACN followed by an incubation of 15 min at 37°C. The 
supernatant containing the peptides was transferred into a new tube. To expand the 
extraction, the gel pieces were additionally covered with 5% formic acid, shaken for 
15 min at 37°C, filled up with the same volume of ACN and incubated for further 15 
min at 37°C. Finally, the supernatant was pooled with extracted peptides from the 
previous step. In order to prepare the peptides for mass spectrometry, the samples 
were desalted by C18 -ZipTip (Millipore, France) according to the manufacturer’s 
protocol and filled in appropriate glass vials. 
3.13 Mass spectrometry analysis  
All LC-MS/MS data obtained by LTQ Orbitrap Velos (Thermo Scientific) were 
analysed using Mascot-Server 2.3.02 (Matrix Science, London, UK) / X! Tandem (the 
GPM, thegpm.org; version 2007.01.01.1) and Mascot Daemon 2.2.06. 
 
The generated peptides originating from the HA-IP experiments were analyzed by 
LC-MS/MS, utilizing the state of the art spectrometer : Thermo Scientific LTQ 
Orbitrap Velos (Thermo Fisher Scientific, USA/Germany) 
LC-MS/MS analyses of desalted samples were carried out on an Acquity 
ultraperformance LC system (Waters) connected to the LTQ Orbitrap XLVelos mass 
spectrometer. The injected peptides were separated on an analytical column (1.7-μm 
BEH130, 75 μm × 150 mm (Waters) with RP buffer A and RP B using linear gradients 
of 120 min or 60 min (depending on sample concentration) at a flow rate of 300 
nl/min controlled with AcquityUPLC software V1.22. The ionization of eluting peptides 
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was performed by using PicoTip emitter needles (New Objective Inc.) at voltages of 
1.7kV and a capillary temperature of 200°C. 
To minimize repeated measurements of peptides, dynamic exclusion was set to 1 
repeat count with 6sec repeat duration and 12sec exclusion duration. 
XCalibur software (Thermo Finnigan).was used to control the Data-dependent 
acquisition of MS and MS/MS data. 
 
Database searches were performed with the following parameters: 
 
Fragment Tolerance: 0,40 Da (Monoisotopic) 
Parent Tolerance: 20,0 PPM (Monoisotopic) 
Instrument type:    ESI-FTICR 
Fixed Modifications: +36 on O (O+36), +57 on C (Carbamidomethyl) 
Variable Modifications: +16 on M (Oxidation) 
 
 
Databases: self compiled database containing 173 DUBs ( homo sapiens and 
mus musculus), NCBI_2011 database ( Homo sapiens) 
Digestion Enzyme: Trypsin 
Max Missed Cleavages: 1 
 
X! Tandem was set up to search a self compiled DUBs database by assuming 
the digestion enzyme trypsin. And was searched with a fragment ion mass 
tolerance of 0.50 Da and a parent ion tolerance of 20 PPM. O+36 of 
pyrrolysine and iodoacetamide derivative of cysteine were specified in X! 
Tandem as fixed modifications, whereas oxidation of methionine was specified 
as a variable modification. 
 
The tryptic-peptides generated by Activity based profiling utilizing HAUB-VFEA, 
were identified by subjecting to MASCOT and X!Tandem (self compiled database).  
 
The tryptic-peptides generated by HA-Immunoprecipitation using UIPPs, were 
identified by subjecting to MASCOT NCBI (2011). 
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3.13.1 Criteria for protein identification and semi quantification 
 
Scaffold (version Scaffold_3.2.0, Proteome Software Inc., Portland, OR) was used to 
validate MS/MS-based peptide and protein identifications. Peptide identifications 
were accepted if they could be established at greater than 95.0% probability as 
specified by the Peptide Prophet algorithm2. Protein identifications were accepted if 
they could be established at greater than 99.0% probability and contained at least 2 
identified peptides. Protein probabilities were assigned by the Protein Prophet 
algorithm 3. Additionally, due to the possibility of some false positive assignments 
originating from the relatively small self compiled database, all proteins were 
manually inspected and verified. 
 
 
3.13.2 MALDI-TOF 
Matrix-assisted laser desorption/ionization (MALDI) time of flight (TOF) was used for 
mass spectrometry analysis / monitoring of product generated during the intein-based 
chemical ligation.  
The samples were prepared by depositing 1µl of sinapic acid protein matrix directly 
on the target plate and mixed afterwards with 1µl of desired sample.  
After the mix solution is evaporated the spots were ionized (Laser)and measured in 
the linear mode. Data were analyzed with software of Bruker Daltonics (Coventry, 
UK), flexAnalysis™ . 
Laser Frequency: 8.3 Hz 
 
Laser Attenator Offset: 70% 
   Range: 20% 
 
3.14 Activity-based shift assay 
In order to prove the reactivity of active site-directed probes towards DUBs, these 
both components were mixed and the labeling potency of the probe was observed by 
a mass shift. This upwards mass-shifted band on the SDS-PAGE corresponds to the 
complex consisting of DUB and the covalently bound probe. Therefore, 0.5 – 1.0 µg 
of recombinant HIS6-tagged DUBs were firstly pre-incubated in a DUB-reaction-buffer 
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for 15min at RT. Afterwards, 0.1-0.5 µg of particular active-site directed probe were 
added and the reaction mix incubated at 37°C for particular period of time. The 
reaction was stopped by adding 4X sample buffer, followed by 95°C incubation for 
3min. Finally, the samples were resolved by SDS-PAGE and analyzed by 
immunoblotting. All experiments were conducted twice or more in the same 
conditions to ensure that the results were reproducible. 
 
3.15 Immunoblotting (Western-Blotting) 
The sample was reduced and alkylated with 4x reducing sample buffer, boiled for 3 
min at 95°C and separated on SDS-PAGE acrylamide gels using the XCell 
SureLockTM Invitrogen equipment. The proteins were transferred for 2h by    “wet 
blotting” procedure using transfer buffer, Polyvinylidene Fluoride (PVDF) membrane 
and Invitrogen equipment (XCell blotting chamber). After the transfer the membranes 
were blocked for at least 3 hours in 5% milk in PBS (0.5% Tween 20) and washed 
afterwards 3x in PBS (0.5% Tween 20). The membranes were then immunoblotted 
with primary antibody diluted in 1% milk in PBS (0.5% Tween 20), washed 3x 15 min 
in PBS (0.5% Tween 20), and followed by 3 times 5 min washes and incubation in 
HRP-conjugated secondary antibody in 1% milk in PBS (0.5% Tween 20). The 
visualization of transferred proteins was performed with a LAS-3000 CCD-camera 
(Fujifilm Europe, Germany) and enhanced chemo luminescence Plus (ECL+) 
Western Blotting Reagent (GE Healthcare, UK).  
 
 
3.16 Gel Electrophoresis 
Shift assay analyses were carried out by using self-cast gels as summarized in Table 
6. Therefore, 0.5-1.0µg of protein were applied to the gel wells and separated at 
100V using Minigel-Twin chamber (Biometra, Germany) and 1X SDS running buffer. 
The PageRuler Prestained Plus Protein Ladder (Fermentas, Europe) was used to 
estimate the protein size. After the separation of proteins according their size, these 
were visualization by Coomassie brilliant blue.  
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Table 6. Composition of stacking and separating gel used for SDS-PAGE analyses. 
Solution stacking gel [ml] Separating gel [ml] 
10% 
Separating gel [ml] 
12% 
SDS buffer A --- 2.5 2.5 
SDS buffer B 2.5 --- --- 
MQ 6.1 4.2 3.5 
Acrylamid/Bis 
(37.5:1) 
1.4 3.3 4 
TEMED 30µl 20µl 20µl 
APS, 10% 60µl 50µl 50µl 
 
 
In order to achieve sufficient separation of proteins in cell lysates, the profiling analysis after 
incubation with the particular probe or after ABPP approach, were carried out with precast 
gradient gels utilizing XCell SureLock®. The instruction for electrophoresis using the XCell 
SureLock® Mini-Cell (Invitrogen, UK) and the technical guide is available at 
www.invitrogen.com/manuels. Therefore, 25-50µg proteins were boiled at 95°C for 3min and 
loaded on the 1.0mm x 10/15 well, NuPAGE® -4-12% Bis-Tris gel. These were separated by 
applying 100V and using 1X NuPAGE® MOPS SDS Running Buffer. 
3.17 Protein dyeing method -Coomassie staining 
In order to visualize the proteins after the SDS-PAGE a dyeing method termed 
Coomassie-Brilliant-Blue-Silver was applied. Therefore, the gel was washed for 
10min with deionized water and fixed overnight in fixing buffer. Afterwards, the gel 
was washed three times with deionized water for 30 min. In order to dye the in-gel 
proteins, the gel was covered with Coomassie-Brilliant-Blue-Silver solution and 
incubated overnight at RT. Finally, the gel was washed with deionized water until the 
protein bands appeared and the blue background disappeared.  
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4 Results 
Deubiquitinating enzymes (DUBs) are involved in many crucial cellular regulatory 
events which directly influence disease and pathologies such as cancer or 
neurodegeneration and thus represent promising therapeutic targets. One important 
open question is the understanding of the molecular basis of DUBs specificity for 
different poly-Ubiquitin linkages and protein substrates. 
To address this issue, promising ubiquitin derived tools termed activity-based probes 
(ABPs) were recently introduced. When these ABPs are applied in an in an activity 
based proteomic approach, these probes bind covalently to the catalytic residue of 
active DUBs and allow to be isolated, identified and characterize the DUBs under 
different physiological conditions. However, the evaluation of DUBs selectivity by 
those ABPs was not possible at the beginning of this thesis project.  
The aim of this study was the improvement of ABPs by modulation of the well 
characterized probe (HAUb-VME) to examine the probe parameters that  are most 
likely influencing the probe reactivity and selectivity. The ultimate aim was the 
generation of novel probes, which are able to bind DUBs selectively and thus give 
insights into  their specificity towards ubiquitin linkages or substrates. 
 
 
For the generation of the C-terminal Ub-ABPs a workflow was 
developed covering the following steps: 
 
 Which stage(s) are improvable in order to optimize the previously introduced 
intein-based ligation128 for generating HAUb derived probes? 
- The optimization steps should include the expression of HAUb, the ligation 
with C-terminal traps and its purification. 
 Which parameters influence the behavior of ABPs? 
- New probes should be designed by systematical modulation of the 
reactivity and generated using an optimized synthesis workflow. 
- The newly generated probes should be evaluated by activity based 
profiling, immunoprecipitation and by binding assay towards recombinant 
DUB. 
 Is it possible to generate highly reactive probes? 
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- Highly reactive probes should be designed and generated. 
- The DUBeome of five different cell lines should be examined by new 
generated probes utilizing functional proteomics.  
 To what extend is it possible  to engineer selective probes by mimicking the 
iso-peptide bond? 
- Novel Di-ubiquitin-mimicking probes should be designed and generated 
based on structural composition of ubiquitin linkages. 
- Case study of representative probes should be conducted by activity based 
profiling.  
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4.1 Generation of novel activity based probes 
4.1.1 Enhanced expression of starting product HAUb 
 
The following description of the employed ligation method contains the significant 
optimization steps, whereas the relevant individual parameters are deposited in the 
method section. 
 
In order to gain functionalized recombinant Ub, which is the starting product and the 
responsible part for specificity in Ub derived ABPs, the HA-Ub-intein-chitin fusion 
construct was expressed in BL-21star E. coli. To optimize the expression conditions 
bacterial cultures were induced with IPTG for 1h, 2h, 3h, and 4h at 20°C in the 
shaking flask and product formation was comparatively analyzed by SDS-PAGE 
(Figure 13a). 
 
Figure 13. SDS-PAGE analysis of expression levels of HAUb in E.coli BL21 using 2L shaking flask (a) 
or 2L fermenter (b). Equivalent amounts of cell pellet were harvested and subjected to the BugBuster 
Protein Extraction reagent. Afterwards, the soluble and insoluble fractions were obtained by 
centrifugation (16000 x g). 50 μg from each cultivation time point was separated by 12% SDS-PAGE. 
The proteins were visualized by Coomassie Brilliant Blue staining. The arrows indicate the expression 
of HAUb-Intein fusion protein, the expression product of interest.  
 
 
The observed product ration increased in the first three hours and kept constant 
afterwards. The observed difference between 3 and 4 hours cultivation time using a 
2L shaking flask was apparently not significant.  
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With the goal to obtain sufficient yield from the intein-based ligation experiments, the 
cultivation time point was extended to overnight (O/N) and the expression induced in 
a 2L fermenter (Figure 13b).  
On the one hand the HAUb expression was not enhanced by extending the 
cultivation time point to O/N, but on the other hand was not accompanied by obvious 
degradation byproducts. However, it has to be kept in mind that in contrast to shaking 
flasks, the fermenter could comprises a considerably higher end volume. In order to 
increase the expression yield and assure the reproducibility of further ligation 
experiments, it was decided to perform an O/N fermentation using a 5 L fermenter. 
The cell pellet yield after fermentation was measured as wet-pellet-mass and came to 
an yield of 200g which is 3 times higher than using shaking flasks. The 
correspondent E.coli growth curve using the fermenter is depicted in Figure 14 which 
shows a representative growth curve.  
 
 
 
 
 
Figure 14. Growth curve of E.coli BL-21 in a 5 L fermenter. 
Time course of relative cell density during the fermentation of E.coli BL21 at agitation speed of 800 
rpm using a 5 L Labfors (Switzerland) fermenter. 
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4.1.2 Improved Workflow for sufficient generation of active site directed 
probes 
Since HAUb-VME is a well characterized Ub-based active site-directed probe, its 
synthesis protocol was selected as a plattform and used as an approved reference73. 
Therefore, a recombinant expressed epitope-tagged Ub fusion protein was modified 
on its C-terminus by applying an intein-based chemical ligation (3.7) (Figure 15a). 
Briefly, a C-terminal fusion construct with an intein-chitin binding domain (CBD) was 
expressed, the cells were pelleted, resuspended and lysed. The suspension was 
clarified and incubated with chitin beads, which bind to the chitin-binding-domain 
present at the C-terminus of the fusion protein.  
 
 
 
Figure 15. Synthesis workflow of activity based probe (ABP) and its validation. (a) Major synthesis 
steps for generation of activity based probes: Step 1, expression of a fusion protein with an intein and 
a chitin binding domain (CBD). Step 2, the fusion protein binds to a chitin affinity column. The HAUb 
was released from the column by a transthioesterification reaction by incubation with MESNa and 
resulted in reactive HAUb75 –MESNa product. Step 3, The MESNa group was replaced by desired C-
terminal reactive group (trap) in a chemical ligation step. (b) HAUb75 –MESNa purification. The 
coomassie stained 12% SDS-PAGE shows the loaded lysate on chitin column; the flowthrough after 
the first and last washing step, and eluted HAUb75 –MESNa collected after on-column cleavage 
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induced by MESNa. (c) Reactivity of the first generated HAUb-VME. The crude cell lysate (30µg) was 
incubated for 2h with 1µl of HAUb-VME, reduced with 4X sample buffer, resolved on 12% SDS-PAGE 
and immunobloted using α-HA antibody.  
 
The addition of mercaptoethanesulfonic acid sodium salt (MESNa) resulted in elution 
of HAUb75 –MESNa (Figure 15b) which lack the C-terminal glycine (G76), but 
carrying a reactive thioester group instead and is capable for chemical ligation. Due 
to the fact that HAUb75 –MESNa is highly reactive and undergoes a fast hydrolysis, 
previous reports suggested to apply it directly to the chemical ligation step. Thus, this 
HAUb derived thioester (HAUb75 –MESNa) was incubated overnight with the 
previously produced amino functionalized trap VME, to generate the desired HAUb-
VME probe (Figure 15a). In contrast to all previous approaches, this ligation step was 
improved by adding Sulfo-NHS as bio-catalyst (as described in section 4.1.3). 
In order to validate the probe reactivity, the generated HAUb-VME was incubated for 
2h with crude cell lysate. Afterwards the sample was resolved by SDS-PAGE and its 
reactivity analyzed by α-HA immunoblotting (Figure 15c). However, in contrast to 
current literature, the labeling reactivity was relative weak and not satisfying. The 
reason was most likely the impurity of HAUb75 –MESNa (Figure 15b, additional 
bands) and the missing information about the probe end concentration.  
In spite of the paucity of ABP purity, most of the previous reports used the ABPs 
simply in excess130. To overcome these limitations, various efforts were made to 
purify the ABP. 
Borodovsky et al. 2005 suggested to dialyze the probe and recommended the 
Pharmacia SMART cation exchange system. Unfortunately, the suggested column 
was not applicable for the ÄKTApurifier™ system used in this thesis work. 
Alternatively, since the pH value was in the range of 6.5-8 pH before and after the 
ligation step, it was obviously to use an anion exchange chromatography without 
additional dialysis steps. Therefore, the usage of MonoQ anion exchange 
chromatography did not allow the purification of the end product, but enable the 
purification of HAUb75 –MESNa (Figure 16a) which guaranteed an efficient 
conversion of the desired probe in the ligation step. Furthermore, in contrast to the 
previously published methods the HA-Ub75 –MESNa thioester was first of all purified 
to remove MESNa which could undergo a competition reaction with thiol-reactive 
groups in the further conjugation step. This purified product was then immediately 
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incubated with previously prepared trap carrying an electrophilic group (Figure 15a) to 
gain the respective ABP of interest by aminolysis of the C-terminal thioester. 
After HAUb75 –MesNa was purified and ligated to VME, the new generated HAUb-
VME was tested by incubation with crude cell lysate (Figure 16b). In contrast to 
previously generated HAUb-VME (Figure 15c) the labeling reactivity increased 
apparently and was represented by additional appearing bands, distributed through 
all kDa ranges.  
 
 
Figure 16. Purification of HAUb75 –MesNa, and the reactivity of the consequent generated HAUb-
VME. (a) The eluted solution obtained from chititin affinity column was adjusted to a pH 7.5 and loaded 
onto a anionic exchange column (MonoQ, GE, self packed). The protein was eluted using a gradient 
from 0 M to 1 M NaCl with a flow rate of 1 ml/min. The obtained fractions (2 mL) were analyzed by 
SDS-PAGE and coomassie staining. (b) Labeling potency of the generated HAUb-VME. The crude cell 
lysate (30µg) was incubated for 2h with 1 µlHAUb-VME, reduced with 4x sample buffer, separated on 
12% SDS-PAGE and immunobloted using α-HA antibody.  
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The potency of new modulated active site directed probes (ABPs) 
 
Regarding recent activity based protein profiling (ABPP) studies and their broad 
application for diverse enzyme classes, the question arises whether it is possible to 
modulate not only the reactivity of the active site-directed probes but also their 
selectivity.  
In the next step, after the probe synthesis setup was established, the intent was to 
modulate the probe reactivity based on the well characterized HAUb-VME.  
In contrast to previous efforts that tried to maximize the reactivity of the probes to 
capture as many DUBs as possible, a systematic approach to modulate the reactivity 
was set up, followed by an additional focus on improving the development of 
selective probes. 
The previously introduced HAUb –VME, as gold standard in terms of high reactive 
probe, is an approved ABP in discovery of DUBs128,131 and was therefore used as a 
reference in this study. To address the dependency of the reactivity on steric 
hindrance and electrophilicity, the HAUb-derived VME probe was first expanded by 
an ethyl ester group (VEE) and then by an additional methyl group on the 
electrophilic carbon (MVEE) of the ,-unsaturated system (Figure 17). 
 
 
Figure 17. Newly generated HAUb derived probes with distinct C-terminal chemical groups. 
Epitope-tagged Ub (HA-Ub) derived probes with different C-terminal reactive groups generated by 
intein based chemical ligation. 
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In order to compare the reactivity and selectivity of the newly developed probe panel, 
all three probes were incubated for 1.5 h with mammalian cell lysates derived from 
Caco2 cells. Covalently modified enzymes (DUBs) were then detected by 
immunobloting using anti-HA antibodies, following protein separation by SDS-PAGE. 
The immunoblot showed comparable clustering of bands from 100 to 140 kDa 
upwards and is consistent with reports 128 about profiling with Michael acceptor 
containing probes. In contrast to clustering, the reactivity/intensity was negatively 
affected and diminished stepwise VME>VEE>MVEE (Figure 18a).  
To proof whether this stepwise reactivity diminishing effect was cell line dependent, 
the ABPs were incubated with the well reported EL4 mouse lymphoma cell lysate73. 
 
 
Figure 18. Distinct activity based protein profiling (ABPP) profiles obtained for total cellular extracts 
treated with HAUb-VME, HAUb-VEE or HAUb-VEE. Caco2 and EL4 cell lysates (30 µg) were 
incubated with 13µl or 10µl respectively of HAUb HAUb-VME, HAUb-VEE and HAUb-MVEE. The 
modified enzymes were separated by 4-12% reducing gradient SDS-PAGE and visualized by α-HA 
immunoblotting.  
 
 
Remarkable was the reproducible stepwise diminished reactivity even after 2h 
incubation with a different cell line lysate (Figure 18b). 
Comparing the ABPs among themselves, immunoblots indicated similar but not 
identical reactivities of HAUb-VEE and HAUb-MVEE. Therefore, the question came 
up, whether HAUb-VEE and HAUb-MVEE have the potency to label specific 
subgroups of DUBs.  
In order to validate the stepwise diminished reactivity and to proof which subgroup of 
DUBs was exclusively labeled by HAUb-VEE or HAUb-MVEE, mass spectrometry 
25
35
40
55
70
100
130
170
kDa
Caco2 -
a b
70
55
35
25
100
130
170
kDa
EL-4 -
Results 
[54] 
 
analyses were used. Therefore, the probes were incubated with total cell lysate (EL-
4) as described above, followed by an anti-HA immunoprocipitation overnight. 
Subsequently, the DUB/probe complexes were eluted and subjected to SDS-PAGE. 
Appropriate gel lanes were excised, trypsin digested to generate tryptic-peptides, 
followed by identification of corresponding proteins (DUBs) via LC-MS/MS mass 
spectrometry. 
 
 
  
Figure 19. Qualiitative analysis of identified DUBs by applying activity based protein profiling (ABPP). 
The selective binding of DUBs was investigated by incubating HAUb-VME, HAUb-VEE or HAUb-
MVEE with crude El-4 cell lysate. After overnight incubation of HA-tagged probes (40µl) with EL-4 cell 
lysate (3.4 mg/ml) followed by α- HA immunoprecipitation, the eluted proteins were separated by SDS-
PAGE and Coomassie stained. Gel-lanes were excised, trypsin digested and analyzed by LC-MS/MS.  
 
 
The immunoprecipitation and mass spectrometry analysis led to the isolation and 
identification of 17 known DUBs, whereas USP8 and UCHL1 were not labeled by 
HAUb-MVEE. Qualitatively, the mass spectrometric analyses revealed that all three 
probes bind basically the same DUBs and did not address specific subgroups as 
observed in immunoblotting analyses above. Moreover, the inspection of raw data 
indicated a slightl variation of applied probes amount (discussed in chapter 5.1). 
Therefore, in order to gain quantitative side by side analysis of probes, it was 
obviously that there was a need to declare the final probe concentration and purity.  
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To address this issue, the end product should be purified after the ligation step. The 
challenge was the small polarity and minor mass difference of the end product in 
comparison to the rest of components present in the ligation mixture.  
Therefore, different columns and conditions were tested to purify the final product 
(e.g. HAUB-VME from HAUb / HAUb75 –MesNa / HAUB-VME). The self packed CIEX 
column MonoS 5/50 showed the best performance. After the column conditions were 
optimized, the purification of the end product showed clearly two separated peaks 
representatively shown for HAUb-VME in Figure 20a. Thus, by using MonoS column 
the tighter elution peaks indicated the right composition of column material, column 
length, and the right conditions.  
Usually, the chromatographic fractions are analyzed by applying SDS-PAGE, 
followed by Coomassie staining to validate the presence of the molecular weight of 
the expected product. This analysis procedure of the fractions is broadly applied by 
structural biologists, which is relatively fast and gives an approximate indication of the 
purity. The fractions containing the product of interest are thus identified and pooled 
afterwards. However, small differences of about 100 Da, which is the case for 
HAUb75 -MESNa  vs. ABP (e.g. HAUb-VME), can be not distinguished properly by 
observing a gel shift on SDS-PAGE. To circumvent this issue in this study, the eluted 
fraction analysis was carried out much faster and with more accuracy by applying the 
available mass spectrometry equipment (MALDI-TOF) instead. An example of the 
fraction analysis using mass spectrometry is provided in the supplementary data 
section (10.7).  
As a consequence, all previously generated probes (HAUb-VME, HAUb-VEE, HAUb-
MVEE) were purified according the established protocol, determined their appropriate 
concentration and were tested for their reactivity. Interestingly, the reactivity of all 
probes was slightly increased but the diminishing reactivity profile pattern (as 
observed before) did not change (Figure 20b).  
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Figure 20. Purification of HAUb75 –MesNa and HAUb-VME and the labeling potency of purified HAUb-
VME, HAUb-VEE and HAUb-MVEE.  
(a) Purification of HAUb-VME by applying CIEX chromatography (MonoS 5/50) after intein-based 
ligation, with a linear gradient from 0% to 80% buffer B, buffer A (50 mM NaOAc -pH 4.5), buffer B (50 
mM NaOAc, 0.5 M NaCl –pH 4.5). (b) HAUb derived probes label distinct sets of proteins in Caco2 
lysate and show distinct activity-based protein profiles. The purificated HAUb-VME derivatives (1 µM) 
were incubated for 2 h with 30 µg Caco2 crude cell lysate, resolved on 4-12 % gradient SDS-PAGE 
and visualized via α-HA immunobloting. (c) Purification of HAUb75 -MESNa by CIEX chromatography 
(MonoS 10/10) after chitin on-column cleavage induced by MESNa. The separation was performed by 
a linear gradient from 0% to 90% buffer B, buffer A (50 mM NaOAc -pH 4.5), buffer B (50 mM NaOAc, 
0.5 M NaCl –pH 4.5). The absorption at 280nm is shown in blue, the gradient of solvent B [%] is 
depicted in green. 
 
 
Additionally, the purification of HAUb75 –MESNa by MonoS –CIEX chromatography, 
showed in contrast to MonoQ purification a significant incease in purity. In 
comparison to Fig. 16, the UV280 nm absorption peak was tighter and the 
Coomassie stained SDS-PAGE presented less background (Figure 20c). It was then 
supposed, that the usage of pure HAUb75 –MesNa would additionally increase the 
ligation efficiency.  
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Therefore, the purification of HAUb75 –MesNa using MonoS was inserted into the 
final probe-generation-workflow. 
To summarize, the probe generation starting from the “simple” workflow (Figure 15), 
was improved by adding two further purification steps, including direct MALD-TOF 
MS monitoring of eluted fractions (Figure 21). Applying MALD-TOF MS analyses 
instead of Coomassie stained SDS-PAGE, allowed even to distinguish between 
HAUb75 –MesNa vs. HAUb-VME and thus the pooling of appropriate fractions.  
 
 
 
Figure 21. Optimized ABP synthesis workflow. 
Major synthesis steps for generation of activity based probes: Step 1, expression of a fusion protein 
with an intein and a chitin binding domain (CBD). Step 2, the fusion protein binds to a chitin affinity 
column. The HAUb was released from the column by on column cleavage induced by MESNa. and 
resulted in HAUb75 –MESNa chemical ligation capable product. Step 3, The HAUb75 –MESNa was 
purified using MonoS 10/10 CIEX chromatography. Eluted fractions were analyzed by MALDI MS and 
pooled appropriately. Step4, subjecting of purified HAUb75 –MESNa to chemical ligation, whereby the 
MESNa group is replaced by desired C-terminal reactive group (trap). Step 5, the end product (probe) 
was purified. Eluted fractions were analyzed by MALDI MS and pooled appropriately. After 
determining the concentration, the desired probes were stored at -80°C. 
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4.1.3 Improving chemical ligation by varying the catalyst  
The classical intein chemical ligation was carried out whereas a synthetic peptide or 
protein carrying the C-terminal alpha thioestergroup was mixed with peptide or 
protein containing an N-terminal cysteine residue. This intermixture ensures the 
highly efficient and chemo selective intermolecular reaction to build the thioester 
connected product. The thioester rearranges to the native peptide bond by an S->N 
acyl transfer. In the present study, this traditional intein chemical ligation was 
modified by using a N-nucleophile instead of the S-nucleophile (cystein residue) as 
described above. This kind of ligation can only be enabled by introducing a N-
hydroxysuccinimide (NHS) (Figure 22a) catalysis, which converts a thioester to an 
amine-reactive NHS ester. This intermediate then has the ability to react with an N-
nucleophile to form a stable amide bond (Figure 22b). 
Importantly, contrary to all previously reported intein-based ligations, the ligation 
method used in this study was improved by subjecting N-hydroxysulfosuccinimide 
(Sulfo-NHS) (Figure 22a) instead of NHS. Sulfo-NHS was much more soluble in an 
aqueous solution and thus more efficient in generating the necessary amine-reactive 
Sulfo-NHS esters. 
 
 
Figure 22.. Structures of NHS and Sulfo-NHS, including the reaction of amine-reactive Sulfo-NHS 
ester and amine on molecule. a) Structures of NHS and Sulfo-NHS chemical modification reagents. b) 
Semi stable amine reactive Sulfo-NHS ester intermediate  #1 react with an amine on molecule #2, 
yielding a conjugate of the two molecules joined by a stable amide bond (modified from Thermo 
Scientific Pierce, www.piercenet.com). 
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4.1.4 Extension of probe repertoire by high reactive probes  
 
Beside the modulation of steric hindrance, the second attempt intended to increase 
the reactivity due to altered electrophilicity by replacing the methyl ester (VME). 
The free carboxy group of the new VA warhead (Figure 23) enabled the introduction 
of fluoro-ethyl substituents. Thereby the preparation of the vinyl monofluoroethyl 
amide (VFEA) and vinyl trifluoroethyl amide (VF3EA) probes was accomplished.  
 
 
Figure 23. Newly generated highly reactive HAUb derived activity based probes containing distinct C-
terminal chemical groups. Epitope-tagged Ub (HA-Ub) ligated with different C-terminal reactive groups 
generated via intein based chemical ligation.  
 
To examine the reactivity of all five newly developed HAUb-derived probes towards 
DUBs, the whole set was subjected to the recombinant deubiquitinating enzyme 
UCHL-3 (Figure 24). The successful labeling of UCH L-3 is demonstrated by a ~ 
10.5 kDa shift, and represents the covalent binding of the respective probe to the 
DUB in vitro. The activity-based DUB shift assay showed distinct labeling profiles. 
The higher reactivity of the HAUb-Monofluoroethyl amide probe compared to HAUb-
VME as indicated before, is also demonstrated in this assay. 
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Figure 24. The potency of newly generated ABPs to bind covalently DUBs.  
Activity profiling assay shows the reactivity of the synthesized HAUb derived active site-directed 
probes with recombinant HIS6-taged DUB UCH-L3. Recombinant  DUB (1µM) was incubated with the 
indicated probe (1µM) at 37°C for 2 h and immunoblotted with anti-HIS6 antibody. Probe reactivity was 
investigated by UCH-L3 shift formed by probe / enzyme adducts. 
 
In order to compare the selectivity of the newly generated probe panel, all probes 
were subjected to a crude cell lysate. For this purposes the well characterized EL4 
mouse lymphoma cell lysate was incubated with the ABPs and modified enzymes 
were visualized by anti-HA immunoblotting (Figure 25). 
 
Figure 25. Distinct activity-based DUB labeling profiles by using newly generated ABPs. The probes 
containing various C-terminal electrophilic groups present distinct activity labeling profiles. Lymphoma 
EL-4 cell lysate (30µg) was incubated with appropriate probes (1µM), separated by 4-12 % gradient 
SDS-PAGE, and immunoblotted with the anti-HA monoclonal antibody. HAUb-VME with known broad 
selectivity spectrum for diverse DUBs, was used as a comparison.  
In terms of additional bands and higher reactivity, the HAUb- derived Monofluoro 
probe (HAUb-VFEA) shows indeed a higher labeling efficiency compared to HAUb-
VME (Figure 25). In contrast, the trifluoro substituted probe shows less reactivity 
towards DUBs. The main difference could be a stronger electron withdrawing effect 
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from three versus one fluorine atom which could influence the coordination into the 
active-site or the stabilization of the probe itself.  
In conclusion, a variation of the substituents of the Michael acceptor demonstrates 
that it is possible to fine tune the reactivity of ABPs. Concerning the reactivity, only a 
stepwise diminishing reactivity, without formation of new bands (Figure 20, Figure 
25) were observed, which most likely indicates a lack of selectivity.  
However, whether the high reactivity observed for HAUB-VFEA also corresponds to 
increased DUB labeling, was initially unclear and is a subject to investigations in the 
next chapter. 
Using the improved synthesis and purification protocol from this study, it was now 
possible to design and synthesize a set of five new ABPs (HAUb-VEE, HAUb-MVEE, 
HAUb-VA, HAUb-VFEA and HAUb-VF3EA) and one reference probe (HAUb-VME). 
These six Michael acceptor containing probes should all react at the position 
corresponding to the C-terminal carbonyl group G76 of ubiquitin, respective of the 
specific position where ubiquitination or deubiquitination occur. Each HAUb-derived 
active site-directed probe was characterized using nanospray time-of-flight mass 
spectrometry (Q-TOF 2 TM, Micromass) by direct injection.  
A representative ESI-MS measurement of ABP products is shown for HAUb-VFEA 
(Figure 26), which represents the observed mass in agreement with the theoretical 
mass. The variation of the theoretical and the observed (measured) mass of only 55 
ppm is an indication for an accurate measurement and successful ligation. The high 
peak intensity and the low background noise indicate the relatively high purity of the 
probe. 
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Figure 26. ESI-MS (Q-TOF) spectra of the ligation product HAUb-VFEA. 
The deconvoluted mass spectrum of the intein-based ligation product showed a mass that 
corresponds to the expected HAUb-VFEA product (theoretical [M+H]
+
= 10641.98, observed [M+H]
+
 = 
10641.40). 
The theoretical and observed masses for all generated probes are listed below. The 
calculated masses were derived from the composition of theoretical mass of HAUb 
(10716.18 Da), the desired C-terminal electrophilic group (Figure 17, Figure 23), 
minus the eliminated water molecule which occur during the liagation step. 
 
Synthesized active site directed probes: 
HAUb-VME - ESI-MS (m/z): [M+H]+ calc.: 10610.95; found, 10610.42     
HAUb-VEE - ESI-MS (m/z): [M+H]+ calc.: 10624.97; found, 10624.20 
HAUb-MVEE - ESI-MS (m/z): [M+H]+ calc.: 10638.98; found, 10638.10     
HAUb-VA - ESI-MS (m/z): [M+H]+ calc.: 10596.94 ; found, 10596.42     
HAUb-VFEA - ESI-MS (m/z): [M+H]+ calc.: 10641.98; found, 10641.40      
HAUb-VF3EA - ESI-MS (m/z): [M+H]+ calc.: 10677.96; found, 10677.10     
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4.2 Distribution of active DUBs in selected cell lines  
4.2.1 DUB profiling using new active site directed probe HAUb-VFEA 
 
Chemical probes are able to report the distinct activity of enzymes, rather than 
merely their expression levels, which defines their functional roles in cell physiology. 
This ability to label enzyme active sites can in some cases even be carried out in 
vivo132,133 and provides high-content proteomic information. One of these approaches 
using chemical probes applies this methodology to covalently label enzyme active 
sites and is termed activity-based protein profiling (ABPP)134. 
In order to evaluate whether the newly developed HAUb-VFEA probe has the ability 
to label a broad spectrum of DUBs, it was therefore applied in an ABPP approach to 
analyze the entirety of available DUBs in four different cell lines. 
The experiment described below (using HAUb-VFEA) to address above question 
were performed together with master student Anne Kummer under my supervision. 
Due to the good characterization and wide applicability in the research field the 
following four cell lines (in addition to EL-4) were used to examine HAUb-VFEA in the 
ABPP approach: HeLa S3, MCF-7, A549 and Jurkat E6-1.  
The cells were grown to 90-100% confluence, harvested and immediately lysed. 
Each cell lysate (9 mg/ml) was incubated with the newly developed ABP – HAUb-
VFEA (0.8 µg) and the covalently bound DUBs were pulled down by anti HA-
Immunoprecipitation. The eluted proteins were trypsinized on beads, purified via 
reversed phase HPLC and analyzed by LTQ-Orbitrap LC-MS/MS. The protein 
identification was carried out by MASCOT database search and the assigned spectra 
evaluated via Scaffold 3.0 (Proteome Software, US). The same workflow without 
HAUb-VFEA was used as a negative control. The experiment was performed in two 
biological replicates and the merged data were used for further Scaffold evaluation. 
Protein detections were accepted if they could be established at peptide probability 
or more than 95,0% and the protein identifications were accepted if they could be 
established at a probability 
of 50,0% or more and contained at least 1 identified peptide 
Results 
[64] 
 
The activity-based protein profiling with HAUb-VFEA achieved a total number of 67 
identified DUBs (Figure 27) including members from all five subclasses, which 
corresponds to a total coverage of 69% of all annotated DUBs.  
 
 
 
Figure 27. Identified DUBs from anti-HA immuno-precipitation using the HAUb-VFEA probe and their 
distribution to the corresponding sub-classes. The DUB sequences were aligned with the ClustalW2
135
 
algorithm and visualized by generation of guided trees using Dendroscope 3.0
136
. 
 
 
Interestingly, also metalloproteases from the JAMM class which contain a Zn2+ 
dependent active site composition could also be detected. However, whether their 
identification is based directly on covalent binding to HAUb-VFEA or through involved 
complexes remains to be clarified in detail. Comparing the modified DUBs among the 
five cell lines, the amount and distribution of detected DUBs seems to be rather 
similar (Figure 28) with the exceptions of the HeLa S3 cell line that in comparison 
expressed relatively more DUBs of the OTU subclass. Taking the activity based 
probing into account, 47 active DUBs were identified in A549, 42 in EL-4, 53 in HeLa 
S3, 56 in Jurkat and 51 in MCF-7. However, in consideration of the activity based 
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profiling, the detected DUB distribution among the cell lines may either be due to 
enzyme activity or abundance. 
 
 
 
Figure 28. Count of identified DUBs and their distribution among four cell lines. DUBs were detected  
by applying HAUb-VFEA in the ABPP approach and their corresponding distribution in different cell 
lines is depicted. 
 
 
 
To examine the distribution of DUBs in these cell lines semi-quantitatively, the LTQ 
LC-MS/MS unique spectra were evaluated with Proteome Software Scaffold 3.0, 
normalized by their molecular masses, clustered with Cluster 3.0137, and visualized 
by Java TreeView138. Thus, the DUBs with their respective MS spectral counts are 
shown as resulted heat maps (Figure 29).  
The cell lines display an overall similar DUB distribution, but also distinct DUB 
subsets were detected. This is illustrated for instance by UCHL3, UCHL5, 
USP4,USP5, USP7, USP8, USP14, USP15,USP19, USP46, USP47, OTU6B and 
OTU7B  that differ in their quantitative occurrence but were identified in all cell lines. 
Other candidates like, USP21, USP29, USP39, USP45, USP54, OTUD3 OTUD5, 
were found only in one cell line. On the other hand, DUBs including OTUB1, OTUB2, 
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UCHL1, USP1, USP3, USP22, USP35,USP38, USP17L2, CYLD  and VCIP135  
show high intensity in certain cell lines only. Beyond the distinct DUB intensities the 
representation by the heat map also revealed subgroups patterns within the cell 
lines. The upper part of the heat map of the USP class seems to represent DUBs 
with high abundance or activity whereas the lower part of the USP class, containing 
the majority of members, displays more specific allocation (Figure 29).  
Furthermore, DUBs like CYLD, USP38, USP20, USP30 show remarkable similar 
patterns intensity of among all cell lines. 
DUBs like OTU7B and OTU6B from the second largest OTU subclass exhibit high 
intensity which corresponds either to high abundance or to high activity in the positive 
cell lines. Interestingly in this class, HeLa S3 cells contain the most detected OTU 
and two exclusive members but at the same time lacks OTUB2. 
Concerning the remaining DUB subclasses UCH and MJD, distinct distribution 
patterns were also detected. Also worth mentioning is the detection of all known UCH 
class members, of which UCHL3, UCHL5 and BAP1 seems to be highly active, 
whereas UCHL1 occurs exclusive only in EL-4 and A549 cell line. Furthermore, the 
MJD subclass is covered by the highly intense Ataxin3 among all cell lines and 
contain by narrowly distributed JOSD1 and JOSD2.   
Although matalloproteases execute a non Cys triggered catalytical mechanism, six 
DUBs could be identified. However, comparing the DUB intensities from the JAMM 
class with other DUB classes it is noticeable that these are considerably weaker. 
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Figure 29. DUBs identification and semi-quantitative analysis in different cell lines by ABPP. 
After 5h incubation of HA-tagged HAUB-VFEA with appropriate cell lysate (9 mg/ml) followed by α- HA 
immunoprecipitation, the proteins were digested directly on beads LC-MS/MS. MS spectral counts 
corresponding to unique peptides (10.4) identified by LC-MS/MS were normalized according the 
molecular weight clustered by Cluster 3.0 and visualized as heatmaps by Java TreeView. (V.1.1.6). 
Ubiquitin-Specific Proteases (USP), Ubiquitin C-terminal Hydrolases (UCH), Machado-Josephin 
Disease domain containing proteases (MJD), Ovarian Tumor domain containing DUBs (OTU), 
metalloenzyme domain containing DUBs (JAMM). 
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To conclude, the ABPP approach using HAUb-VFEA clearly demonstrated the high 
reactivity of HAUb-VFEA towards DUBs and detected both widely as well as specific 
distributions of active DUBs in distinct cell lines, whereas the Jurkat cell line 
contained the highest number of detected DUBs. 
 
 
4.3 Generation of isopeptide bond mimicking ABPs to cast 
insights of the specificity and selectivity of DUBs 
The molecular mechanism of DUB specificity for different poly-Ubiquitin linkages and 
substrate proteins are still poorly understood. The previously introduced ABPs 
attempt to address this issue, but due to their broad and high reactivity do not provide 
information on the substrate selectivity or linkage specificity of DUBs. While the 
labeling specificity of probes can be partially tuned, proteases that do display 
restricted substrate selectivities might escape the generic probe labeling approach. 
 
4.3.1 The concept, design and sought out parameters for novel ABP 
Under the consideration that the previously described ABPs were only a poor 
structural mimetics of substrates which DUBs likely encounter in the cell, it was 
reasoned that features of the ubiquitinated target protein should be implemented in 
the probe design to improve the specificity. Therefore, the intent was to develop a 
new class of ABPs for characterizing the selectivity of DUBs. A novel branched 
Ubiquitin Isopeptide Activity Based Probe (UIPP) was engineered in order to address 
the specificity of different DUBs, their detection, enrichment and to gain further 
insights into deubiquitination machinery (Figure 30). Instead of modifying one 
ubiquitin unit only C-terminally, an approach to generate mimetics of a di-ubiquitin or 
of any ubiquitinated target protein was established. To achieve such probe specificity, 
the UIPPs incorporate the isopeptide linkage and the target sequence of the 
ubiquitinated protein of interest allowing it to achieve the desired probe specificity. 
The distal ubiquitin unit is expressed as recombinant protein linked via its C-terminus 
to the ε-amino group of a lysine within a synthesized peptide which mimics the 
proximal Ub unit. The peptide sequence can in principle also be derived from any 
ubiquitinated target protein. Previous studies that used Ub-peptide based substrates, 
demonstrated that a minimal chain length of 8 amino acids is already sufficient to 
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evoke DUB reactivity10. On the other hand the peptide length should not exceed 20 
amino acids to avoid proteasomal degradation139-140. The peptide design was also 
based on structural considerations with the aim to mimic the native fold. Thus, those 
constructs could be promising to capture ubiquitin linkage-specific DUBs. 
 
 
 
 
 
 
Figure 30. Novel systematically designed ubiquitin isopeptide activity based probes (UIPPs). The 
innovative UIPP concept mimics the isopeptide bond between two Ub-molecules or Ub-molecule and 
protein, which is the DUB substrate, and thereby enables the formation of a covalent bond between 
the particular DUB and its substrate. The property of covalent capture is given by the intrinsic reactivity 
of the Michael acceptor group, highlighted in red. The specificity was achieved by full length ubiquitin 
and the chosen peptide sequence, originating from next Ub-unit or the target protein of interest, 
shaded in green.  
 
The close inspection of ubiquitin sequence in context to ubiquitin-linkages revealed 
that each of the seven lysine residues in Ub create an unique sequence and 
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structure, which might be used for specific recognition by DUBs30 (Table 7). 
Therefore, this insight was used for the rational behind the design of chain specific 
Ub-isopeptide probes. 
Recent biochemical characterizations have revealed  the specificity relevance of this 
C-terminal sequence, showing that the fourth and third amino acid (Arg74 and Gly75 
) are crucial for ubiquitin recognition by DUBs141. This relevance was also validated in 
the first structure of a DUB with a diubiquitin, which illustrates the Ub-linkage 
specificity of AMSH-LP due to the specific recognition of the Lys63 sequence 
context106. For the new probe design it was thus reasoned that it is sufficient enough 
to use a peptide fragment that contains the side-chain-modified lysine residue 
derived from the proximal Ub unit. To enable the covalent capture of DUBs with 
particular linkage specificity, the novel UIPPs are equipped with a Michael acceptor 
group in direct proximity to the isopeptide bond. For the preparation of the UIPPs the 
previously introduced modified intein-based chemical ligation (3.7) was used.  
 
Table 7. Ubiquitin linkage context for all types of polyubiquitin chains. 
Linkage residues Ubiquitin (lys) linkage context  Accessible nearby 
residues 
Ub-Lys6 Phe, Val, Lys6, Thr, Leu  His68, Thr66, Thr12 
Ub-Lys11 Thr, Gly, Lys11, Thr, Ile  Thr9 
Ub-Lys27 Val, Lys27, Ala Glu24, Asp52 
Ub-Lys29 Ala, Lys29, Ile Asp32, Glu18 
Ub-Lys33 Gln, Asp, Lys33, Glu, Gly Not explicit 
Ub-Lys48 Phe, Ala, Gly48, Lys, Gln, Leu Ala46 
Ub-Lys63 Asn, Ile, Gln63, Lys, Glu Not explicit 
Modified and extended from Urbé et al. (2009). 
4.3.2 Synthesis of Ubiquitin Isopeptide Activity Based Probe (UIPP) 
As one of the new C-terminal ABPs in the “probe-tuning” experiments (4.1.4), glycine 
vinyl formic acid (VA) was synthesized, which is the key intermediate for the 
preparation of the UIPPs. VA was used to selectively modify the -amino-group of 
lysine within a peptide which had been synthesized by Fmoc solid phase peptide 
synthesis. The VA-modified peptide (Table 8) was then used in a modified intein-
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based chemical ligation to generate the isopeptide bond between the free amino 
group of the VA modified peptide and the C-terminus of a recombinant HA-Ub75-
thioester. The UIPP construct that resulted after chemical ligation carries the Michael 
acceptor group instead of Gly76, which is bound to the -amino group of the lysine 
within the Ub mimetic peptide (Figure 31a). Thus this construct mimics a di-Ub unit 
while carrying an electrophilic reactive group next to the isopeptide bond for covalent 
capture of DUBs. To validate the UIPP concept, the well studied K48- and K63-
polyubiquitin linkages were selected. Thereby two ubiquitin derived peptide 
sequences containing a thiol reactive group and a single free amino group (Table 8) 
were subjected to a chemical ligation with HAUb75 –MESNa to generate two di-Ub 
mimicking probes (K48-UIPP: HAUb-Ub42-54 –K48(VA) and K63-UIPP: HAUb-Ub42-54 –
K63(VA)) respectively (Figure 32).  
 
 
Table 8. Properties of the thiol reactive peptide traps used for the synthesis of novel UIPPs. 
Isopeptideprobe Peptide sequence Mass  
Ub(42-54) –K48(VA) 
(K48-UIPP) 
Ac-RLIFAG-K48(VA)-QLEDGR-NH2 
 
1626.936 
Ub(54-72) –K63 (VA) 
(K63-UIPP) 
Ac-RTLSDYNIQ-K63(VA)-ESTLHLVLR-NH2 2410.327 
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Figure 31. Synthesis of ubiquitin isopeptide activity based probe (UIPP). a) The generation of desired 
UIPPs is achieved by the chemical ligation mechanism from the intein-based ligation approach.. The 
capability for covalent capture is given by the intrinsic Michael acceptor properties of the substructure 
highlighted in red. The specificity was achieved by full length ubiquitin and the chosen peptide 
sequence, originating from next Ub-unit or the target protein of interest, shaded in green. b) Ubiquitin 
originating peptide sequences containing a C- terminal thiol-reactive group, were subjected to a 
chemical ligation (a) to generate the desired UIPPs which mimic the K48 or K63 ubiquitin linkage.  
 
 
 
All HAUb-derived UIPPs were characterized using nanospray time-of-flight mass 
spectrometry (Q-TOF 2 TM, Micromass) via direct injection.  
The successful generation of novel K48/K63-UIPP products is illustrated below 
(Figure 32), which represents the observed mass in agreement with the theoretical 
mass. 
The difference between theoretical and observed (measured) mass of 43 ppm for 
K48–UIPP and 40ppm for K63–UIPP, is an indicative for an accurate measurement 
and successful ligation, since these values are in the range of the accuracy of the 
instrument resolution. The high peak intensity and the low background noise indicate 
the relatively high purity of the probe. 
 
 
a) 
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b) 
 
Figure 32. ESI-MS (Q-TOF) spectra of the ligation products K48-UIPP (a) and K63-UIPP(b). 
The deconvoluted mass spectrum of the intein-based ligation products showed a mass that 
corresponds to the expected UIPP products (theoretical K48-UIPP [M+H]
+
= 11768.5, observed 
11768.0, theoretical K63-UIPP [M+H]
+
= 12551.9, observed 12551.4). The masses 11636.6 and 
12419.6 are explained by loss of N-terminal methionine due to the bacterial methionine amino 
peptidase (MetAP) activity in E.coli.  
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The theoretical and observed masses are listed below. The calculated masses were 
derived from the composition of theoretical mass of HAUb (10159.6 Da), the desired 
C-terminal electrophilic peptide sequence (Table 8), minus the eliminated water 
molecule which occur during the liagation step. 
 
Generated Ubiquitin Isopeptide Activity Based Probes: 
HAUb-Ub(42-54) –K48(VA): 
ESI-MS (m/z): [M+H]+ calc.: 11768.5 ; found, 11768.0 
HAUb-Ub(54-72) –K63(VA): 
ESI-MS (m/z): [M+H]+ calc.: 12551.9 ; found, 12551.4 
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4.3.3 UIPP reactivity and selectivity  
As proof of concept two UIPP probes (Figure 33a) were generated and used for a 
case study to test their selective binding to DUBs with known poly-Ub linkage-
specificity. The two UIPPs that were generated and used in the assay were designed 
to either mimic K48-linked di-Ub (K48-UIPP) or K63-linked di-Ub (K63-UIPP) 
respectively. Applying these probes in a shift assay, recombinant USP15, which is 
known to bind both K48- and K63-linked poly Ub chains
104 reacted with both UIPPs, 
confirming the expected reactivity of both probes. In contrast to USP15, for UCH-L3 it 
has been suggested that it hydrolyses K48-linked byproducts from proteasomal 
degradation processes142 and indeed, recombinant UCH-L3 showed a clear 
preference for labeling by K48-UIPP. Furthermore, applying the UIPPs and 
recombinant Ataxin-3 in the shift assay, no reactivity could be observed (Figure 33b). 
These observations show the ability of UIPPs to selectively and covalently label 
DUBs in vitro. 
 
Figure 33. Selectivity of novel isopeptide probes towards recombinant DUBs (UCH-L3, USP15 and 
Ataxin-3) in vitro. (a) Chemical structures of the generated K48- and K63-linkage UIPPs.  
(b) Selectivity of the K48- and K63-UIPPs towards recombinant DUBs. Recombinant HIS6-tagged UCH-
L3, Ataxin3 and USP15 were incubated for 10 min with the UIPPs, separated by 12% SDS-PAGE and 
immunoblotted with an anti-HIS6 monoclonal antibody. Probe selectivity was investigated by checking 
the formation of UCH-L3 /Ataxin3/ USP15 probe-enzyme adducts. The band representing the UCH-
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L3-K48-UIPP adduct (outlined in red, was isolated, digested with trypsin and analyzed by MALDI-TOF 
MS/MS (Figure 34). 
 
 
In order to confirm the ability of the UIPPs to covalently capture DUBs by targeting 
their active site, a shift assay as shown in Figure 33 was carried out, followed by 
Coomassie staining. The up shifted band (outlined in red) was trypsinized and 
analyzed by MALDI-MS. Besides the fragments corresponding to either UCH L-3 or 
Ub, the tryptic peptide containing the active site cysteine residue of UCH-L3 
covalently bound to the isopeptide probe could also be detected (Figure 34). 
 
 
Figure 34. MALDI-TOF MS peptide mapping of the UCH-L3 - Ub42-54-K48(VA) isopeptide probe 
covalent adduct. Peptides originating from tryptic digestion of the complex of UCH-L3 ( * ) and 
ubiquitin (■) isopeptide probe (Fig. 2b) were detected by MALDI-TOF MS using the Mascot (Matrix 
Science) search engine (Sprot database, 1 missed cleavage, precursor tolerance: 100 ppm). Next to 
UCH-L3 and Ub derived tryptic peptides, an additional mass peak (m/z 3523.81) was detected 
corresponding to the fragment of DUB/probe –complex (theoretical mass 3522.87, [M+H]
+
 = 3523.81,), 
mapping the covalent adduct to the UCH-L3 derived peptide 89-108 (see inserted scheme).The delta 
mass can be attributed to that trypsin converts the C-terminal amide on the synthetic peptide (ends on 
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Arg) to free carboxylate. Additionally, the isopeptide probe was found to be covalently bound to the 
active site cysteine (Cys
95
) present in the UCH-L3 derived peptide as confirmed by MS/MS 
fragmentation analysis (data not shown). 
 
 
4.3.4 Novel UIPPs in biological applications 
In cases where the DUB specificity information is missing, the iso-peptide probe can 
be used to “fish” a subset of DUBs with distinct specificity. For this purpose, a probe 
can be incubated with a crude cell lysate, followed by immunoprecipitation, protein 
digestion and mass spectrometric analysis. As a proof of the profiling capacity, the 
K48-UIPP and K63-UIPPs  were incubated with crude Jurkat cell lysate, separated by 
SDS-PAGE, and immunoblotted with anti-HA antibody (Figure 35). The ABP–HAUb-
VME used as a ontrol shows a broad reactivity, whereas both UIPPs display both 
common and distinct activity profiles, underlining their different linkage specificities.  
 
 
Figure 35. Activity-based profiling using novel UIPPs reveal distinct labeling patterns. Jurkat cell 
lysates (25 µg) were incubated with the indicated UIPPs,  resolved on 4-12% gradient SDS-PAGE, 
and immunoblotted with anti-HA monoclonal antibody. 
 
DUB identification was achieved using a functional proteomics approach by 
incubating the UIPP probes with the cell lysate, followed by immunoprecipitation of 
the covalently bound protein with anti-HA antibody-agarose beads. Precipitated 
proteins were eluted, seperated by SDS-PAGE and visualized by Coomassie staining 
(Figure 36). Proteins of the K48-UIPP, K63-UIPP and HAUb-VME gel-lanes were 
trypsinized and the derived peptides analyzed by LTQ-Orbitrap LC-MS/MS. To 
highlight the specificity differences of UIPPs, corresponding unique spectra were 
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clustered and visualized using a heatmap (Figure 36). The ABPP approach with 
HAUb-VME revealed  34 identified DUBs in total whereas a subgroup of 22 was 
captured by the UIPPs in a partially complementary way. Regarding the subgroup, a 
cluster of preference could be obtained for K48-UIPP as well as for K63-UIPP 
whereas only 3 (USP28,USP12,USP22) out of 22 DUBs were specifically captured 
by K48-UIPP. It is important to note that, the distribution of UIPP-DUB labeling 
specificity is more graded and not exclusively UIPP allocated. However, a good Ub-
linkage evidence was observed for USP5, 7, 10, 12, 22, 28 and USP9X which show 
a strong preference for UIPP-K48, whereas K63-UIPP preferentially labeled USP16, 
19, 38 and BAP1. 
The data presented here demonstrate that the novel UIPPs are selective labeling 
reagents for DUBs and can efficiently capture their targets in an activity-dependent 
manner in crude cell lysates and in vitro. Therefore, this novel ABP approach seems 
to be an ideal tool to study DUBs selectivity towards ubiquitin-linkage specificity not 
only in vitro but also in a more biological environment. Due to its novelty, the UIPP 
constellation was patent.  
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Figure 36. HAUb derived active site-directed UIPPs containing various thiol-reactive  groups show 
distinct activity labeling profiles. The selective binding of DUBs was investigated by incubating K48- 
and K63-UIPPs with crude Jurkat cell lysates. After 1h incubation of HA-tagged UIPPs with Jurkat cell 
lysate (6.25 mg/ml) followed by α- HA immunoprecipitation, the eluted proteins were separated by 
SDS-PAGEand Coomassie stained. The  excised gel-lanes were  trypsinized and analyzed by LC-
MS/MS. Heatmap of DUBs identified by incubating K48- and K63-UIPPs with crude Jurkat cell lysates. 
MS spectral counts corresponding to unique peptides (supplementary table 2) identified by LC-MS/MS 
were normalized with Scaffold 3.0 (Proteome-Software, Portland), and visualized with TreeView 
(V.1.1.6). 34 DUBs were detected by HAUb-VME (VME), whereas a subgroup of 22 DUBs was also 
labeled by UIPPs in a partially complementary fashion.  
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5 Discussion 
5.1 Modulation potency of active-site directed probes 
The utility of ABPs for mechanistic studies has been repeatedly confirmed by new 
studies. Recent mechanistic studies , e.g. addressing the E3 ligase ARF-BP1, 
revealed the importance of multiple cysteine residues for its ubiquitination activity by 
using HAUb-VME143. Similar studies also demonstrated the usefulness of C-terminal 
variation to address further enzyme groups like E3 ligases but did not improve the 
capture selectivity within one enzyme class. Furthermore, the specificity-conferring 
part of the probe assemblage (e.g. Ub), is a very important component that 
dramatically influences probe selectivity144 and can stabilize proteins for 
crystallization purposes as well108. 
Concerning the ABP modulation attempts in this study, beginning with C-terminal 
variations of HAUb-VME, fine-tuning of reactivity was more successful than that of 
selectivity. Examination of the label profiling showed comparable intensity clustering 
upwards of 100 kDa and diminished enzyme labeling downwards (Figure 20b, Figure 
25), which is consistent with recent reports for profiling with Michael acceptor 
probes131,130. Probe reactivity clearly is negatively affected by the structure of the 
reactive groups, which was deduced from the systematical extension from VME to 
VEE and further to MVEE. Thus, the VME-derived probes showed graded reactivity 
(VME>VEE>MVEE), corresponding to increasing steric hindrance, whereas the 
overall labeling efficiency was diminished and did not show additional specificity 
representing bands. 
It must be noted that the effect is not the same for each band as  for some of the 
bands the effect is stronger, which suggests that some DUBs seem to be more 
sensitive regarding higher steric demands. Unfortunately, these observations were 
only in conformity with HAUb-MVEE, which was not able to bind UCHL1 and USP8 in 
the immunoprecipitation assay (Figure 19). Nevertheless, closer inspection of raw 
data in terms of intensity and spectral counts did not conform with the expected 
stepwise diminishing effect, as described above. In addition, UCHL1 and USP8 
belong to different DUB subclasses, show a sequence homology of only 5.4% 
(ClustalW) and there are absolutely no  indications in the literature from which one 
could infer that the absence of probe-binding to these DUBs was due to their 
specificity.  
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However, the immunoprecipitation assay illustrated the capability of probes to bind 
DUBs covalently and revealed 17 identified DUBs.  
 
To conclude, the attempt of modulating only the C-terminal electrophile of current 
ABPs offers the chance to modulate the reactivity but not the selectivity of HAUb 
derived probes.  
However, a broad reactivity towards DUBs might be useful for large scale profiling 
approaches intending to explore the diversity of DUB expression in different tissues, 
cell lines or stimulating experiments.  
The higher reactivity of the HAUb-VFEA probe compared to HAUb-VME as 
mentioned before is also observed in the reactivity band shift assay (Figure 24). This 
fact was confirmed by an additional band detected at around 40 kDa, which is also 
slightly visible after labeling with HAUb-VME. Running a 12% SDS-PAGE, staining 
with Coomassie, excising the band followed by tryptic digestion identified UCHL3 as 
the contents of this additional band (data not shown). The occurrence of UCHL3 in 
this lower running band (ca. 40 kDa) was also confirmed by the manufacturing 
company Enzo Life SciencesR and specified as truncated UCHL3.  
It has been shown previously that fluorine could interact favorably with peptidic N-H, 
and might orient the ligand towards electronegative regions of receptor sites145. Thus 
in addition to the electron-withdrawing effect, which causes higher electrophilicity at 
the β-carbon of the Michael acceptor group, introduction of a fluoro-substituent might 
also cause a favorable pre-orientation of the ABP and should be considered in further 
probe designs. However, as the comparison of diminished reactivity from monofluoro- 
to trifluoro-substituted probe demonstrated, the implementation of multiple fluro-
substituents should be carefully considered. The reduced reactivity in case of 
trifluoro-substituent may duo to highly electron withdrawing effect which also leads to 
probe instability.  
To conclude, there are still potentials to modulate the probe reactivity by amplified 
incorporating of steric hindrance and electronwithdrawing components. 
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5.2 High abundance versus high activity, correlation between 
ABPP and transcriptomic data 
Numerous studies have applied activity-based protein profiling (ABPP) using 
chemical probes that are active-site directed and thus detect the activity status of 
proteins in complex mixtures. This begs the question: Which factors directly affect 
measured parameters and which of these contribute to DUB identification? From the 
biological point of view the identification could depend on the amount of expressed 
protein and its current activity status. As a complement to that, the probe affinity, 
reactivity and its amount influence the DUB identification during the ABPP approach 
as well. 
To address the question concerning the correlation between activity and abundance 
of detected DUBs in different cell lines, mRNA data from BioGPS146 were extracted 
and correlated with the ABPP data from this study. BioGPS is a gene annotation 
portal that includes gene annotations and relationships from the NCI-60 panel of 
human cancer cell lines147. In the following correlation analysis the EL-4 cell line was 
excluded due to missing information in BioGPS.  
The correlating interpretation of mRNA and ABPP data described below underlie the 
assumption, that mRNA data represent protein expression level whereby ABPP data 
the abundance of active proteins.  
In order to evaluate these two datasets from the objective perspective, a 
classification into different subgroups was carried out. 
The classification criteria into subgroups include mRNA intensities, MS spectral 
counts, their correlation and the level differences in all four cell lines. 
The overall comparison between mRNA and ABPP data indicated three major groups 
(i) correlated, (ii) partially correlated and (iii) not correlated (Figure 37).  
 
 
The main criterion for the division into the correlated group was the relationship 
between ABP and mRNA, which was retained through all cell lines. Therefore, the 
progression of levels (trend) together with the correlation of ABP and mRNA 
(positive/negative sign) was taken into consideration (e.g. – ABP/+mRNA (MCF-7), - 
ABP/+mRNA (A549), …). 
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The relevance for the assignment to the “partially correlated” category was the partial 
consistence of the trend and the sign of the levels from ABP and mRNA data, which 
were not maintained through all five cell lines. 
The “not correlated” category covers all other candidates, including those without any 
observable trend of cell lines, without any correlation between ABP/mRNA data and 
some cell line types with missing ABP data. Moreover the classification took 
candidates into account, whereas the numbers of unique spectra and mRNA intensity 
(x axis) varied dramatically.  
The first group shows parallel good correlation between the mRNA and ABPP 
datasets and is representatively shown for USP22 and USP15 (Figure 37a). The 
DUBs assigned to this subgroup maybe regulated more at the DNA/RNA level. High 
protein abundance is also supported by high counts of MS spectra in the ABPP 
approach. In addition, recent reports148,149,150 on USP22 corroborate this assumption 
also. However, the mRNA expression level does not necessarily correspond to the 
amount of active protein in a cell. In case of USP4, which is also sorted to the first 
group, a recent study detected an auto-inhibited form after translation151. In this case 
the DUB is functional but not active, and probably activated after the structural 
rearrangement induced by binding the active site-directed HAUb-VFEA. 
About 39 % of the detected DUBs that differ in their ratio and the level trend 
regarding one or two cell lines were classified to the second “partial correlated” 
subgroup.  
Representative examples for this group are UCHL3 and USP47 (Figure 37b). 
UCHL3 displays an obvious inconsistence for mRNA as shown for A549 and HeLa, 
while the spectral counts are more equally distributed. Taking into account the high 
intensity scaling for mRNA, the functional importance and high activity of UCHL3, the 
data are consistent with the available literature84. The differences between the cell 
lines might indicate that UCHL3 could be used as a marker for cells (cell lines) from 
diseased tissues.  
With respect to USP47, the cell lines MCF-7 and A549 illustrate a controversial 
correlation. 
Nevertheless, the mRNA data are consistent in comparison with large-scale tissue 
mRNA profiling data152. The high spectral count and mRNA levels of USP47 suggest 
both high activity and functional importance of this DUB, which indeed is supported 
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by a recent publication demonstrating its importance for DNA repair and maintaining 
genome integrity153. 
The third classification subgroup comprises of 46% of DUBs without any correlation 
of mRNA and ABPP dataset. Two representatives of this subgroup shown shown for 
examples are USP1 and USP2 (Figure 37c). The high variations between mRNA 
and ABPP data could indicate a regulation on both ways, either at the transcriptional 
level or through different protein activity. Furthermore, these observations suggest a 
directed DUB regulation in certain cell lines / tissues depending on DUB functionality, 
as shown in a recent report for USP1, where the authors describe that USP1 
expression in mesenchymal stem cells stabilized ID proteins, inhibited osteoblastic 
differentiation, and enhanced proliferation154. Remarkable for USP2 is the low 
intensity (see scaling of both y-axes) that might hint at a more sensitive regulation of 
this DUB, an observation that is certainly worthwhile following up in additional 
experiments.  
Further comparison diagrams (ABP data versus mRNA data) can be provided on the 
request by Cellular Proteom Research group (HZI). 
To conclude, the more general overview of classification of DUBs in the three 
presented subgroups demonstrates a valuable comparison between transcriptomics 
and protein activity data. Concerning these data, it seems that DUBs are mostly 
regulated post-translationally, since most of the DUBs were classified to the third “no 
correlation” subgroup. All DUBs in this group are lacking a correlation between 
mRNA and ABPP data, therfore it is highly likely that their activity is regulated 
separately. Furthermore, post-translational modifications play a role in regulating the 
activity of DUBs, such as reported for Ataxin3 whereas the catalytic activity status is 
influenced by its ubiquitination155, or by phosphorylation for OTUB1156. In addition, 
DUB activity is also affected by certain conformational changes157,109, as already 
mentioned in the introduction. The mRNA studies presented here together with the 
ABPP data using HAUb-VFEA suggest that the absence of correlation in mRNA and 
ABPP data is due to distinct DUB regulation mechanisms rather than just enzyme 
appearance. Regarding the activity of proteins, active site-directed probes can 
provide high content proteomic information about the active state of enzymes and 
their active site conformation in vivo.  
In addition, attention should be also paid to the fact that the applied concentration of 
HAUb-VFEA in this study was considerably low when compared to all previously 
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published ABPP investigations. The increase of concentration can enhance the 
reactivity / sensitivity but on the other hand also reduce the specificity.  
The data presented in this study supply the research community with the information, 
which probe could  be used in which cell line in order to get access to a particular 
DUB. This information could be useful for the choice of an appropriate cell line for the 
design of DUB-oriented projects.  
For instance , in order to perform functional studies with USP35, it is recommended 
to use MCF-7 as an appropriate cell line. 
Therefore, it would be desirable for this case to have already representatively DUB-
profiled cell lines, permitting an easy selection of the right cell line for the intended 
study of a particular DUB or vice versa.  
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a) Correlated  
  
b) Partial correlated 
   
c) No correlation  
 
Figure 37. Comparison of mRNA and the obtained ABPP data using HAUb-VFEA. Depicted are 
mRNA and ABPP spectral count data for correlation purposes. Chosen are DUBs which are 
representative for the following groups a)correlated, b)partial correlated, and c)no correlation. The 
extracted mRNA data from the NCI-60 cell panel
147
 (BioGPS) covered 39 DUBs also detected in the 
ABPP approach using HAUb-VFEA. The counts of unique spectra are shown on the primary y-axis, 
the mRNA-intensities on the secondary y-axis. In case of multiple spots on a microarray the intensities 
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were averaged. The diagrams of the remaining DUBs can be found in the supplement. Picture partially 
adapted from Anne Kummer (Master Thesis).  
 
5.2.1 HAUb-VFEA profiling potency towards metalloproteases 
Previously introduced ABPs158,108 and the probes from this study were engineered to 
target conserved nucleophiles in the active site of proteases. Taking the differences 
of the MP catalytic mechanism159 into account, their direct targeting by HAUb-VFEA 
can likely be excluded. Furthermore, several JAMMs are allocated in protein 
complexes and thus were more likely pulled down as a byproduct of protein 
complexes such as the proteasome, which may explain the low detected intensitys in 
contrast to other DUB subclasses. Accordingly to this observation, further 
investigations have to be carried out to clear the remained question whether all other 
less detected DUBs were pulled down as byproducts as well. 
However it is clear that HAUb-VFEA is a functional and highly reactive active site-
directed probe and it could be managed to retrieve these DUBs successfully even 
though the probe was not originally designed to achieve this. 
Nevertheless, considering certain existing examples of electrophile-based covalent 
inhibitors160and covalent probes proven effective for presenilin161 and creatine 
kinase162, Alan Saghatelian and colleges engineered recently also an ABP for 
MPs163. 
 
5.2.2 Comparison of HAUb-VFEA versus gold standard HAUb-VME  
Posttranslational interactions and modifications modulate the functional state of 
enzymes and different large-scale profiling methods have been applied to monitor 
these. One such technique is termed ABPP and uses the popular active-site directed 
probe HAUb-VME, which was first designed in 2002128. In five different studies 
utilizing HAUb-VME the identification of 46 DUBs was described7-9,167,168. 
Regarding the DUB profiling in the mostly used EL-4 cell line, 29 DUBs were 
detected using HAUb-VME128,166, compared to 42 DUBs labeled by HAUb-VFEA in 
this study.  
The direct comparison of the “gold standard” HAUb-VME and HAUb-VFEA shows an 
overlap of 44 commonly labeled DUBs (Figure 38). Concerning the DUB identification 
and the distribution in their DUB subclasses, HAUb-VFEA labeling covered 
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exclusively 23 additional DUBs distributed among all subclasses. In contrast, HAUb-
VME additionally modified 2 DUBs, USP13 and A20. The list of identified DUBs used 
for the comparison is provided in the supplement section 10.5. 
 
 
 
Figure 38. Comparison of DUBs identified by the new HAUb-VFEA versus “gold standard” HAUb-VME 
(Venn diagram). All detected DUBs identified by HAUb-VFEA in this study versus DUBS labeled by 
HAUb-VME, are summarized from all known ABPP-HAUb-VME approaches performed to 
date
73,128,131,130,169-58
. 
 
 
Several previous studies have utilized HAUb-VME but were predominantly carried 
out in the EL-4 cell line. HAUb-VME will certainly may have the potential to detect 
more DUBs in further cell lines, Since the labeling power of probes is restricted also 
by (i) probe property, (ii) the performance of measuring apparatus and (iii) at the 
biological system itself128. 
These points clearly show the advantage of HAUb-VFEA, which was already utilized 
in profiling experiments of different cell lines by using state of the art instruments. 
Huib Ovaa et al. 2004 for example, showed the activity profiles of DUBs in different 
cell types using HAUb-VME, but detected in summary only 11 DUBs. 
Thus, the utilization of up to date instruments could allow to increase the sensitivity 
and the more detailed description of DUB profiles between different cell types. 
However, the direct evaluation and the high number of 16 DUBs exclusively captured 
by HAUb-VFEA (in contrast to all HAUb-VME reports up to date) suggest a broader 
reactivity and thus, is more than comparable with HAUb-VME. 
In summary, HAUb-VFEA demonstrates increased reactivity compared to HAUb-
VME and is a suitable active site-directed probe for DUB profiling approaches. 
 
 
2 44 23
HAUb-VME HAUb-VFEA
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5.3 The potency of novel UIPPs 
In contrast to recently introduced synthetic di-Ubiquitines170, the newly developed 
UIPPs possess a Michael acceptor system instead of Gly76 of the distal Ub, thus 
enabling the covalent capture of DUBs. This allows for the capture and sampling of 
DUBs with distinct target specificities, and formation of stable DUB-UIPPs complexes 
facilitates crystallization attempts. Knowledge of target specificities and structure of 
the enzyme bound in its active conformation is also important for the design of 
specific inhibitors of DUBs 
 
5.3.1 Evaluating the reactivity and selectivity of recombinant DUBs 
using UIPPs  
 
The gel shift assays of UIPPs demonstrated not only the reactivity but a certain 
potency for DUB selectivity as well (Figure 33b). In addition, the presence of only 
one (rather than multiple) up-shifted band hints at reactivity towards one active 
cystein residue143.  
The reactivity of USP15 towards both UIPPs provides a kind of guideline, a hint to its 
Ub-linkage preference, and is consistent with current knowledge of its 
deubiquitination specificity104. USP15 and USP4 are closely related proteins 
containing both an integrated Ubl fold within the catalytic domain and share a 
sequence identity of 70%. A recent publication established that the catalytic activity of 
USP4 is regulated by its Ubl fold, and closely related proteins, such as USPs 6, 11, 
15, 19, 31, 32 and 43, probably also regulate DUB activity through their Ubl 
domain151. Thus, the observed UIPP reactivity supports again the importance of 
“activity- based probes”.  
In contrast to USP15, UCHL3 has been reported to be able to cleave K48 linked poly-
Ub but not K63-linked poly-Ub
104,171,172. The gel shift assay with recombinant UCHL3 
certified a clear preference for binding to the K48-UIPP and supports the assumption 
that UCHL3 may recognize proteasomally pre-processed K48-linked proteins
142.  
Regarding Ataxin-3, recent studies observed that di-Ub chains, whether K63- or K48-
linked, are unsuitable Ataxin-3 substrates173,174. Additionally, the Ub preference was 
evaluated by crystallography using HAUb-chloroethylamine, which allowed the 
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determination of the first crystal structure for a Josephin-Ub complex and attests 
once again the potential of ABPs in structural analysis175.   
 
The DUB Ub-linkage specificity concerning the sequence context141,106 could be 
remarkably demonstrated by proof of concept UIPPs with the chosen peptides, Ub(42-
54) –K48(VA) and Ub(54-72) –K63(VA). 
There can be no doubt that the interaction of distinct amino acids from both, 
substrate and residues in the active site of DUBs, contribute to DUB specificity.  
Importantly, the prerequisite for their correct orientations is determined by structural 
constraints. The sequence length of the investigated peptides (K48-Pep: Ub(42-54) –
K48(VA), K63-Pep: Ub(54-72) –K63(VA)) was deliberately chosen to cover these 
structural features from ubiquitin and contains indeed different structural components 
(Figure 39). On the one hand, the K48-Pep poses a compact structure and is shorter 
than K63-Pep, which might explain the high preference of UCH L-3 towards K48-UIPP 
(Figure 33b). On the other hand, K63-Pep provides more sequence context and is 
much more flexible in comparison to the ordered structure of K48-Pep. (Figure 39a). 
Thus it should fit better into the catalytic groove of a DUB. Beside the structural 
aspects, each peptide contains a different potential distribution which attributes to 
distinct charge preference in the catalytic groove as well. For example K48-Pep. 
presents a positive charged area around K48 which suggest that this to interact with 
DUBs which display more negative charged surface around the active-site.  
Additionally, K63-Pep exhibits more hydrophobic surface patches (Figure 39b) and 
therefore should have more potential to interact with the DUBs. However, the applied 
gel shift assay (Figure 33b) demonstrated different DUBs preferences towards 
UIPPs, which cannot be explained by peptide length or structure alone, but obviously 
depends on the DUB binding sites as well. The cases where UIPPs did not bind the 
DUB can be attributed firstly to the sequence context of the five missing Ub-linkages 
(K6, K11, K27, K29, K33) and secondly to the lack of further hydrophobic ubiquitin 
patches, which naturally interact with certain DUB domains.  
Furthermore, due to a similar structural element (β-sheet) around the Ub-linkage, it 
can be postulated that K6 and K11 polyubiquitin chains have the same function as 
K48 polyubiquitin chains. The participation of K11 polyubiquitin chains in proteasomal 
degradation was also recently reported77. In contrast, the lysines K27, K29 and K33 
jut out from an α-helix (Figure 1) and thus may serve for other cellular functions. 
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These structural deductions are presently only hypotheses but should nevertheless 
being considered when evaluating these unconventional and poorly understood 
ubiquitin chains.  
 
 
Figure 39. Potential distribution and hydrophobicity mapping of Ub(42-54)–K48(VA) and Ub(54-72) –
K63(VA) peptides used for the UIPP design. (a) The calculations by DelPhi webserver show distinct 
potential distribution and hydrophobic areas on the surface of the ubiquitin-derived peptides. The 
lysines (K48 and K63) shown as sticks are exposed on the surface and ready to engage in interactions. 
(b) Molecular surface is colored by the hydrophobicity of the residues according to the Eisenberg scale 
(Eisenberg et al., 1984). The pictures were generated using The PyMOL Molecular Graphics System, 
2008 (PDB-ID: 1UBI).  
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5.3.2 Application of UIPPs in biological environment 
 
The ABPP approach with UIPPs clearly highlights the potential of the new UIPPs to 
capture and characterize linkage-specific DUBs from cell lysates (Figure 36). 
Although the reactive groups of HAUb-VME and the UIPPs are similar, the 
comparison of detected DUBs certifies again the high reactivity of HAUb-VME and 
the ability of UIPPs to label a particular subgroup of DUBs. However, it has to be kept 
in mind that this is a proof-of-concept study and only two (K48/K63) out of seven 
possible Ub-linkages were mimicked. Taking this into account, mimicking the other 
five Ub-linkages using the UIPP design, a coverage of 39 DUBs and more can be 
expected. A further important point is the difference of covered DUB classes. 
Interestingly, only two (USP and UCH) out of five DUB classes were targeted by the 
present ABPP/UIPP approach, although ABPP/HAUb-VME addressed at least one 
DUB out of four DUB classes (USP, UCH, OUT, MJD). CYLD (USP class) and 
Ataxin-3 (MJD class) for instance, seem to prefer K63 polyubiquitin linkages176,173, 
whereas A20, as an OTU class member, prefers K48 polyubiquitin in vitro104. On the 
other hand in vivo studies, as for A20, describe its cleavage preference for K63 
polyubiquitin chains. This example again represents the discrepancy between in vitro 
and in vivo studies and highlights the lasting need for clarification of DUB linkage 
preference, and using probes such as UIPPs in vivo would be an important step 
forward. The DUBs of the fifth class (JAMM) were generally missing, which is most 
likely due to the different catalytic mechanism of metalloproteases, as discussed 
already in the introduction section.  
Why UIPPs didnot label DUBs from other DUB classes stil has not been completely 
understood, although for some of these the deubiquitinating preference for K48/K63 
Ub-linkages are well described. An explanation could be that the remaining DUBs 
(covered only by HAUb-VME) cleave polyubiquitin chains exclusively, since UIPPs 
mimic more a di-Ub or distinct branched Ub variant, rather than polyubiquitin. 
Furthermore, the DUB-Ub substrate recognition is not fully understood to date and 
often depends on the additional DUB-internal multiple Ubiquitin Binding Domain 
(UBD), which first binds a number of ubiquitin variants in order to activate the DUB 
catalysis104.  
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The labeling of certain DUBs by UIPPs  may not be realized which could be 
explained by the fact that UBD is missing in the UIPP design, but is needed for the 
DUB activation. 
Additionally, the polyubiquitin recognition and processing by DUBs can be performed 
as whole chain amputation, distal/endo trimming or long-chain binding15,177 (Figure 
40) and have to be taken into account for the evaluation of Ub-linkage preferences. 
Especially for K63-linked polyubiquitin chains it remains to be clarified whether these 
chains are cleaved from their proximal or distal ends. 
 
 
 
 
Figure 40. Possible mechanisms of polyubiquitin recognition by DUBs. 
A) DUBs can recognize both, the target protein and the polyubiquitin chain. B) DUBs can trim the 
polyubiquitin chain beginning with distal ubiquitin. C) DUBs may bind simultaneously two ubiquitins by 
interacting with both ubiquitins that surround the isopeptide bond. D) DUBs could recognize 
polyubiquitin through the use of multiple UBDs. Ubiquitin is depicted in blue, the target protein in 
green, and the polyubiquitin receptor in red (Reyes-Turcu & F.E. Wilkinson, K.D, 2009). 
 
 
 
According to the “Ub-linkage preference” illustrated by heat maps (Figure 36), K48-
UIPP is highly reactive towards USP5. Interestingly, this finding is in accordence with 
shift assay (in this study) and a recent publication, which established that USP5 
recognizes the C-terminal Gly-Gly motif and also is a known dedicated ubiquitin 
recycling DUB, which is highly active against unattached Ub-chains as well178. 
Regarding USP7, the preference for K48-linked di-Ub was recently reported179. 
Nevertheless, labeling of DUBs by both UIPPs also gives a clue about their Ub-
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linkage specificity. DUBs which are likely to be multifaceted in their Ub-linkage 
specificity, like USP15, which is consistent with recent literature was also labeled by 
both UIPPs104. In addition, it has been suggested that certain USP members show 
cross-reactivity to ubiquitin-like proteins, such as NEDD8, as well180. 
 
To answer this question, the generation of UIPPs including any conceivable Ubl-
derived peptide sequence could be used for the assembly of Ubiquitin-like Isopeptide 
Activity Based Probe (UBL-IPP). With this strategy it is now possible to modify each 
lysine of the target protein with ubiquitin via an isopeptide linkage thatcontains the 
reactive Michael acceptor group. This opens up not only the possibility to synthesize 
UIPPs with all seven possible di-Ub linkages, but also to derive peptide sequences 
from putative ubiquitination sites181 of distinct target proteins. This represents a 
significant advantage as compared to examining their specificity using recombinant 
enzymes, as the enzymatic properties of DUBs may change within their biological 
environment.  
Nevertheless, the ABPP approach with novel K48/K63-UIPPs already provides 
substrate selectivity for only 34 DUBs, but it should be stressed that this represents a 
sizable subfraction of ~100 human genome-encoded DUBs, which bind either K48 or 
K63 Ub-linked chains. According to this, the result of profiled DUBs represents a 
specific DUB-sub-proteome. 
To conclude, the application of UIPPs in different induction assays, such bacterial 
infections, could provide a certain DUB sub-proteome and at the same time 
information about their substrate selectivity.  
Furthermore, the evaluation of DUB’s Ub-linkage preference using UIPPs followed by 
DUB implementation in signaling pathways can provide useful information about its 
biological significance. Taking this into account, one example will be presented for 
USP7, serving as proof-of-concept, followed by discussing the infection-associated 
DUB USP19182. 
The reported interaction between p53 and USP7 (HAUSP) serves as an ideal 
representative example. Recent studies described the deubiquitinating activity of 
USP7 towards p53 and its protection from proteasomal degradation by acting as a 
direct antagonist of Mdm2 (E3 Ub-ligase)183. Since all proteins labeled with K48-
polyubiquitin chains are destined for proteasomal degradation it is believed that p53 
is likely to be labeled with K48-polyubqiuitin chains. This widespread assumption is 
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supported by the UIPP-ABPP results in this study, where USP7 shows a clear 
preference for K48-UIPP.  
Furthermore, functional studies indicating that the binding of Epstein-Barr nuclear 
antigen 1 (EBNA1) to USP7 inhibits its deubiquitination of p53184, suggests that some 
viruses alter the activity of USP7 to manipulate the proteasomal cellular events. 
In cases like USP19, the cellular function and interaction network is not as well 
described as for USP7, thus UIPP-ABPP results could give important and exiting 
insights into their biological relevance. Due to the fact that USP19 is a relatively large 
enzyme of 145 kDa, the recombinant expression and biochemical characterization is 
not a simple task. All USP19 publications up to date have indeed reported 
deubiquitinating activity, but not the types of Ub-linkages that were processed. The 
last reported function of USP19 was the transcriptional modulation of major 
myofibrillar proteins185 and that its resides on the ER to most likely rescue the ERAD 
substrates from degradation182. Since USP19 showed a clear preference for the K63-
UIPP probe (Figure 36), further examination with those interacting proteins should be 
carried out in the context of K63-linked ubiquitination. Also, further USP19 knock-
down or silencing experiments should not only be evaluated in terms of degradation 
but also in the context of induction in transcription, protein sorting into the 
multivesicular bodys186, autophagic clearance187, protein trafficking and DNA repair31. 
Besides the possibility to elucidate the ubiquitin linkage specificity of DUBs by using 
UIPPs, the UIPP approach could also be used to identify DUBs which deubiquitinate 
particular targets. In case of substrates where the ubiquitination site is known, the 
development of specifically constructed UIPPs could enable the detection of DUBs 
which most probably regulate their ubiquitin status, for instance DUBs in the E-
cadherin pathway.  
E-Cadherin is an epithelial cell-cell adhesion receptor, forms a key component of 
epithelial cell adhesion, and plays an important role during developmental 
morphogenesis and wound healing188. Recent reports demonstrated that the surface 
protein (InlA) of Listeria monocytogenes interacts with E-cadherin, triggers its 
ubiquitination and promotes the internalization of the bacterium189.  
Although it was reported that E-cadherin is ubiquitinated by the ubiquitin-ligase 
Hakai, its antagonist (DUB) is still unknown. Due to the implication of E-cadherin in 
different signal transduction pathways, the interaction network is relatively broad and 
covers various possible DUBs (Figure 41).  
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Figure 41. Schematic plot of USP19 and its interaction partners constructed with 2011 Ingenuity 
Systems.  
 
 
Thus, it remains a challenge to identify the DUB responsible for the deubiquitination 
of E-cadherin. The generation of specific UIPPs containing the sequence that covers 
the ubiquitination site of E-cadherin (Figure 42) could solve this issue and represent 
an unprecedented tool. Furthermore, the application of an E-cadherin-UIPP in a 
functional proteomic approach has the advantage to address many DUBs in a single 
experiment.  
In addition, the access to DUBs and their monitoring during Listeria infection using 
probes developed in this study could reveal how intracellular Listeria influence host 
DUBs.  
 
 
DUBs interacting with CDH1 
and are identified
by chemical proteomics
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Figure 42. Schematic model of an UIPP constellation to discover possible DUBs which regulate the 
ubiquitin status of E-cadherin during Listeria monocytogenes infection. 
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6 Outlook 
The most obvious next step of development is to continue to improve of the reactivity 
and selectivity of ABPs as well as their applicability in ABPP approaches. The pilot 
approach of systematically modulating HAUb-VME reactivity demonstrated that in 
future for instance the probe reactivity might be enhanced by introducing a more 
electron-withdrawing group including Fluorine. HAUb-VFEA, designed in this study, 
showed a slightly higher reactivity as the gold standard HAUb-VME and could be 
utilized for a broad range of activity-based DUB profiling experiments. However, to 
ensure the wide range reactivity for exploring the DUB profiles in further profiling 
experiments it would be an advantage using a mixture of different ABPs, similar to 
already commercial available inhibitor cocktails. Such a strategy would be sensible, 
e.g. to profile the DUB activity before and post infection to identify DUBs that are 
putatively involved in the infection process of interest, as described for UCHL1190.  
After choosing a DUB of interest from a DUB profiling experiment the same or a more 
selective ABP could be used to enrich this DUB and examine it for PTMs, which may 
explain its up or downregulating activity. This kind of analysis could be performed by 
mass spectrometry and would give insights into the PTM status in a more biological 
context, an advantage compared to in vitro modifications.  
Furthermore in order to expand the utilization of probes for in vivo application, the 
development of cell permeable probes would allow profiling enzymes directly in living 
cells. First experiments to realize such probes have already been published191. These 
probes are mostly based on small molecules to ascertain their ability to cross the 
membrane. Unfortunately Ub-derived probes, which are more selective towards 
targets related to the native substrate Ub, cannot passively permeate the cytoplasmic 
membrane. Additionally, probes containing the HA tag are not cell permeable per 
se192. To meet this challenge the HAUb-derived construct could be reduced to two 
peptides containing instead HA another tag, such as a FLAG tag. Another completely 
different approach would be the utilization of cell penetrating peptides (CPPs) which 
have the ability to shuttle proteins or even nanoparticles into living cells193. Moreover, 
fluorescent probes developed in the last decades allow a “real time” imaging of the 
dynamic assembly, localization and turnover of target proteins in living cells194. 
The design of mechanism-based probes directed against receptors or proteins in the 
cell membrane would even allow imaging distinct cell types and under optimal 
conditions replace antibodies. Nevertheless, the combination of antibody-linked 
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active site-directed probes may provide more target specificity and would be a novel 
attempt, which was not attempted until now.  
The creation of ABPs based on Ubiquitin-like proteins such as Nedd8, ISG15 and 
SUMO has already been demonstrated130 and is a promising innovation which should 
further be developed to shed light on the function of these poorly investigated protein 
modifications. In addition, their characterization could be facilitated by structure 
analyses as there are as yet no structures of ISG15 or NEDD8 bound to DUBs 
available.  
The fact that ubiquitin-like modifications were mainly observed monomeric and not 
forming poly-Ubl chains suggests that these kinds of modifications could be more 
easily mimicked by the UIPP approach as well.  
Although the UIPP strategy is at an early stage of development, it illustrates the 
potential of peptide integration for studying the chemistry of DUB selectivity. The 
advantage of peptides as specificity-contributing units was recently demonstrated 
with photo-activated cross-linking of peptides in studies of the human hypoxia 
inducible factor system195. Further advantages of using peptides were already 
covered in the discussion section, e.g. mimicking a whole ubiquitinated protein by 
combining ubiquitin and a peptide originating from the protein of interest. This 
construct could be incubated with a crude cell extract followed by 
immunoprecipitation, and can thus disclose the DUB that is very likely responsible for 
regulating the ubiquitination status of the “mimicked” targeted protein.  
The current understanding of DUB specificity is still incomplete, due to among other 
things, the unavailability of well-defined ubiquitin chain substrates or assays. This 
issue could be addressed by generating the further five UIPPs to cover all possible 
ubiquitin chain linkages.  
Despite the elegant design at using peptides, the idea could be extended to 
implement full length ubiquitin using the recently patented and published UB 
synthesis protocol from Huib Ovaa’s lab170. 
In general terms, the latest increase of covering sub-proteomes by ABPP focuses 
mainly on hydrolase activities and should be extended to other enzyme classes. 
Recently notable examples, such as the whole ABP panel from Cravatts laboratory 
directed against multiple cytochrome P450s196 have been published. Additionally, the 
Lin group recently described  ABPs targeting cell surface receptor CD38197, and first 
ABP attempts from Licht et al. were directed towards ion channels198. The advantage 
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of the ABPP approach is the utilization of the natural affinity of native ubiquitin, 
permitting the use of enzymes combined with small active site-directed probes. This 
advantage could be used not only to profile enzyme activities or test the affinity of 
inhibitors in competitive assays, but also for probe design based on already validated 
inhibitors for certain enzymes. This kind of approach would clearly accelerate the 
development of additional ABPs. Furthermore, generating ABPs by using drug 
compounds as a source of proven inhibitors may be a practical approach to evaluate 
their affinity. Thus, development of inhibitors with widespread affinity could be 
avoided and the side effects resulting from this would be prevented in the first place. 
In order to improve pharmaceutical relevance of ABPs, the last and ultimate goal 
would be the integration of ABPP into several high-throughput technologies to 
facilitate the understanding of enzyme function in complex biology networks and 
pathologies resulting from their malfunction. A good step forward with a 
multidimensional profiling strategy that combines activity-based proteomics and 
metabolomics199 was recently demonstrated. 
The present study established the potential of broadly reactive ABPs, their fine-tuning 
and paved the way to generate more selective activity-based probes. The availability 
of such ABPs would facilitate the proteomic analysis of pathogens to identify new 
targets and alleviate the search for new drugs against multi-resistant strains. To 
investigate this possibility Staphan Sieber’s group recently used a small generated 
library of β-Lactones and applied ABPP to prokaryotes to identify specific target 
enzymes, which are crucial for bacterial viability and virulence200,201. 
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7 SUMMARY 
Ubiquitin is a 76-amino-acid protein and contains seven Lysine residues at the 
positions 6, 11, 27, 29, 33, 48, and 63. The covalent attachment of ubiquitin via the 
C-terminus of ubiquitin to lysine residues of target proteins (or ubiquitin itself) is 
termed ubiquitination and is a widespread regulatory post-translational modification. 
Beside monoubiquitin also topologically different polyubiquitin chains (Ub-linkages) 
exist which regulate a wide range of cellular processes. As with most other post-
translational modifications, ubiquitination is a reversible process, which is enabled by 
deubiquitinating enzymes (DUBs) that remove the ubiquitin or truncate (trim) 
polyubiquitin chains. Therefore, DUBs have an analogous role to phosphatases and 
are functionally as important as ligases or kinases, thus representing an attractive 
therapeutic target. Unfortunately, the mechanism and function of DUBs are poorly 
understood and recent research efforts focused on the development of suitable 
biochemical tools to obtain new insights into the specific mechanisms of members of 
this recently discovered enzyme class. Useful tools termed activity-based probes 
(ABPs) are implemented by conversion of ubiquitin into a suicide substrate, which 
possesses a C-terminal reactive group. By utilizing the ABPs in a functional 
proteomics approach, these probes interact and bind covalently to the catalytic Cys 
residue of active DUBs. However, because of their relatively unspecific binding of 
different DUB proteases and thereby broad reactivity, the examination of all aspects 
of DUB selectivity and specificity cannot be addressed. The aim of this study was the 
improvement of the ubiquitin ABP by generating specific probes to clarify DUB 
linkage and substrate specificity issues. In addition, the novel designed probes 
should be validated and evaluated in respect to their biological applications in 
functional proteomics experiments.  
The ABP synthesis procedure described in previous publications was improved by 
additional purification steps and by utilizing Sulfo-NHS as a nucleophilic catalyst.  
To investigate the reactivity profile of ABPs two directions were pursued: the 
dependence of DUB labeling on steric hindrance and the influence of increased 
electrophilicity by fluorination. Concerning steric hindrance, the reactivity diminished 
stepwise by expanding the gold standard ABP (HAUb-VME) with an ethyl ester group 
(VEE) and further by additional attachment of a methyl group to the electrophilic 
carbon atom (MVEE). However, the effect of increased electrophilicity by replacing 
SUMMARY 
[102] 
 
alternatively the methylester from HAUb-VME with a monofluoroethylamide-group 
(HAUb-VFEA) showed indeed higher labeling efficiency compared to HAUb-VME.  
To conclude, using the improved synthesis protocol, it was possible to design and 
synthesize a set of five new ABPs (HAUb-VEE, HAUb-MVEE, HAUb-VA, HAUb-
VFEA and HAUb-VF3EA), showing distinct activity-based DUB labeling profiles. 
The activity-based protein profiling using the most reactive probe (HAUb-VFEA) 
designed in this study revealed an overall of 67 active DUBs in five different cell lines 
(A549, EL-4, MCF-7, Jurkat E6-1 and HeLa S3). These results demonstrate not only 
the high reactivity of HAUb-VFEA but also show the distinct active DUB populations 
of each cell line, respectively. The focus of the next investigation was the 
development of novel ubiquitin-based ABPs to also allow targeting of DUBs with 
distinct Ub-linkage specificities. The intention was to develop a new class of ABPs for 
characterization of the Ub-linkage preference of DUBs within the activity profiling 
assay. The result was novel peptide branched Ubiquitin Isopeptide Activity Based 
Probes (UIPPs). In contrast to standard ABPs, the novel UIPPs contain not only the 
ubiquitin with a C-terminal reactive group, but also an additional freely selectable 
peptide sequence. The peptide sequence can originate from ubiquitin or from any 
ubiquitinated target protein. Thus, an UIPP mimics an isopeptide bond present within 
di-ubiquitin or an ubiquitination site from a protein of interest. This constellation 
represents a new type of ubiquitin-based reactive probe concept and was patented in 
2011. 
Due to the fact that DUBs distinguish the Ub-linkages most likely by Ub-linkage 
sequence context, the well studied K48 - and K63 polyubiquitin linkages were 
mimicked to validate the UIPP concept. Indeed, the respective probes showed a 
selective labeling behavior towards USP15, UCHL3 and Ataxin-3 in an activity shift 
assay, thus validating the peptide based approach. The ability of the UIPPs to 
covalently capture DUBs by targeting their active-site residue was further confirmed 
by mass spectrometry analysis. 
Using cell lysates, the activity-based profiling comparison versus HAUb-VME 
indicated also their potential of capturing different Ub-linkage specificities from 
complex proteomes.  
In order to evaluate the DUB Ub-linkage specificity in more detail in a biological 
environment, a functional proteomics approach was applied to crude cell lysates. 
Good evidence for Ub-linkage preference was observed for DUBs such as USP5, 7, 
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10, 12, 22, 28 and USP9X which show a strong binding preference for K48-UIPP, 
whereas K63-UIPP preferentially labeled USP16, 19, 38 and BAP1. 
In conclusion, the ABPs and UIPPs created in this study were found to be enabling 
tools to capture active DUBs and study their selectivity towards ubiquitin-linkage 
specificity in a complex proteome. The crystallization of DUBs in their active 
conformation in complex with UIPPs would provide an important advance towards the 
design of specific inhibitors of DUBs. It can be expect that the use and application of 
UIPPs may facilitate drug design and expand the repertoire of targeted molecular 
therapies. 
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7.1 Zusammenfassung 
Ubiquitin ist ein kleines aus 76 Aminosäuren bestehendes Protein und beinhaltet 
sieben Lysinreste an den folgenden Positionen: 6, 11, 27, 29, 33, 48, 63. Die 
Kovalente Bindung von C-terminalen Ende des Ubiquitins mit dem Lysinrest des 
Zielproteins wird Ubiquitinierung bezeichnet und ist eine weitverbreitete 
posttranslationale Modifikation. Neben der Monoubiquitinierung existieren auch 
topologisch verschieden Polyubiquitinketten (Ubiquitinverknüpfungen) die ein breites 
Spektrum an Zellulären Prozessen regulieren. Wie auch bei anderen 
posttranslationalen Modifikationen, ist die Ubiquitinierung ein reversibler Prozess, 
wobei das Ubiquitin durch Deubiquitinierungs Enzyme entfernt oder die Polyubiquitin 
Ketten verkürzt werden. Demnach, sind DUBs ein Analogon zu Phosphotasen und 
funktionell ebenso wichtig wie Ligasen oder Kinasen und repräsentieren somit ein 
attraktives therapeutisches Ziel. Bedauerlicherweise ist der Mechanismus und die 
Funktion von DUBs nur wenig verstanden und deswegen sind derzeitige 
wissenschafliche Bemühungen fokussiert geeignete biochemische Tools zu 
entwickeln, um eine Einsicht in den spezifischen Mechanismen von diesen erst 
kürzlich endeckten enzymklasse zu bekommen.  
Vielversprechend sind die Aktivität basierten Sonden (activity based probes -ABPs) 
dessen Aufbau ein modifiziertes Ubiquitin beinhaltet, welches am C-terminus eine 
reaktive Gruppe trägt. Bei der Anwendung dieser ABPs im funktionsbasierten 
Proteomiks Ansatz interagieren diese mit aktiven DUBs und binden kovalent an 
dessen katalytischen Aminosäurenrest. Allerdings zeigen diese eine unspezifische 
Bindung und eine breit gefächerte Reaktivität auf, so dass die Untersuchung der 
DUBs hinsichtlich Ihrer Selektivität und Spezifität nicht möglich ist.  
Ziel dieser Arbeit war es die Reaktivität der Sonden weiterhin zu verbessern und  
die fundamentale Frage der DUB Spezifität anhand neue entwickelter, spezifischer 
Sonden zu klären. Dabei sollten die neu designten Sonden synthetisiert, validiert und 
im biologischen Kontext mit der funktionalen Proteomik evaluiert werden. Das zuvor 
in der Literatur beschrieben Syntheseprotokoll wurde durch zusätzliche 
Aufreinigungsschritte und den Zusatz von S-NHS, einem neuen Bio-Katalysator, 
deutlich verbessert. Das Reaktivitäts-Verhalten der ABPs wurde anhand der 
Abhängigkeit der molekularen  sterischen Hinderung und des Einflusses von 
elektrophilen Grupen untersucht. Ausgehend von dem Gold Standard-ABP (HAUb-
VME) und der systematischen Erweiterung mit einer Ethyl Gruppe (zu HAUB-VEE) 
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und einer weiteren Methyl Gruppe (zu HAUB-MVEE), nahm die Reaktivität 
stufenweise ab. Dennoch, das alternative Ersetzen der Methylester Gruppe von 
HAUB-VME mit der Monofluorgruppe (HAUb-VFEA) zeigte eine höhere Reaktivität im 
Vergleich zum Goldstandard HAUB-VME.  
Zusammengefasst, unter Verwendung des verbesserten Syntheseprotokolls ist es 
gelungen fünf neuartige ABPs (HAUb-VEE, HAUb-MVEE, HAUb-VA, HAUb-VFEA 
und HAUb-VF3EA) mit unterschiedlichen aktivitätsabhängigen DUB Bindungsprofilen 
zu synthetisieren. Das aktivitätsbasierte Profiling unter Verwendung des neuen hoch 
reaktiven HAUb-VFEA ermöglichte das detektieren von 63 aktiven DUBs in fünf 
verschiedenen Zelllinien (A549, EL-4, MCF-7, Jurkat E6-1 and HeLa S3). Diese 
Ergebnisse repräsentieren nicht nur die hohe Reaktivität von HAUB-VFEA, sondern 
zugleich auch das „DUBeom“ der einzelnen Zelllinien.  
Der nächste Fokus dieser Arbeit war die Entwicklung neuer ABPs durch Einführung 
zusätzlicher Elemente die die Spezifität der DUBs hinsichtlich der Ubiquitin-
Verknüpfung ansprechen. Die Intention war es eine neue Klasse von ABPs zu 
implementieren die es ermöglicht die DUBs Präferenz hinsichtilich der Ubiquitin- 
Verknüpfung  in einem aktivitäts-basierten Assay zu profilen.  
Das Resultat war eine neue Art von reaktiven Ubiquitin-Peptid basierten Sonden 
(Ubiquitin Isopeptide Activity Based Probe (UIPP)).  
Im Gegensatzt zu standard ABPs beinhalten die  UIPPs nicht nur Ubiquitin mit einer 
C-terminalen reaktiven Gruppe, sondern noch eine zusätzliche frei wählbare 
Peptidsequenz. Im Prinzip kann diese Peptid Sequence entweder von Ubiquitin oder 
von einem erdenklich ubiquitinierten Protein stammen. Demnach ist ein UIPP eine 
Nachahmung von einem Di-Ubiquitin oder einer Ubiquitinierung von gewünschten 
Proteinen. Da diese Konstellation eine völlig neue Art vom reaktiven Tool darstellt, 
wurde diese 2011 patentiert.  
Aus dem Fakt, dass die DUBs die Ubiquitinverknüpfungen höchstwahrscheinlich 
anhand der Konsensus Sequenz unterscheiden, wurden die gut charakterisierten K48 
- und K63 Polyubiquitin Verküpfungen ausgewählt um das UIPP Konzept zu 
validieren. Ein Aktivität-Shift-Assay zeigte in der Tat ein selektives Verhalten 
gegenüber USP15, UCHL3 und Ataxin-3, welches auch für den Peptid basierte 
Ansatz spricht. 
Die Fähigkeit der kovalenten Bindung an das aktive Zentrum von DUBs wurde 
anhand Massen Spektrometrischer Analysen bestätigt.  
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Das aktivitätsbasierte Profiling im Zelllysat versus HAUB-VME deutete ebenfalls auf 
dessen Potential verschiedenen Ubiquitinverknüpfungen zu imitieren. 
Der Funktionelle Proteomiks Ansatz in einem Zelllysat evaluierte die Spezifität 
bezüglich der Ubiquitinverknüpfung in einem mehr biologischen Milieu. Gute 
Anzeichen wurden für DUBs wie USP5, 7, 10, 12, 22, 28 und USP9X beobachtet, die 
eine deutliche Bindungspräferenz zu K48-UIPP aufzeigten, wobei K63-UIPP 
vorzugsweise USP16, 19, 38 und BAP1 gebunden hat.  
Zusammengefasst, die in dieser Arbeit neu entwickelten ABPs und UIPPs 
repräsentieren ein ideales Tool zur Anreicherung von aktiven DUBs und für die 
Charaktereisierung dessen Spezifität bezüglich Ubiquitinverknüpfungen in einem 
biologischen Milieu. Die Kristallisation von DUBs in ihrer aktiven Konformation 
komplexiert mit UIPP würde ein wichtiges Requisit bieten, welches zur Generierung 
neuer DUB Inhibitoren nützen könnte. 
Es kann angenommen werden, dass die Verwendung von UIPP das Drug Design 
beschleunigen und das Repertoire an molekularen Therapien erweitern könnte. 
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10 Supplement 
 
10.1 Ubiquitin sequence 
 
 
Ubiquitin amino acid sequences of two ubiquitin constructs used in this study.  
 
1-pTyb2HAUb - was used for generating of HAUb-VME, HAUb-VEE, HAUb-MVEE, 
HAUb-VFEA, HAUb-VF3EA. 
 
ATGGCTAGCTCGCGAGTCGACTACCCATACGATGTTCCAGATTACGCCGAATTC
ACCATGCAGATCTTCGTGAAGACTCTGACTGGTAAGACCATCACCCTCGAGGTT
GAGCCCAGTGACACCATTGAGAATGTCAAGGCAAAGATCCAAGATAAGGAAGG
CATCCCTCCTGACCAGCAGAGGCTGATCTTTGCTGGAAAACAGCTGGAAGATG
GGCGCACCCTGTCTGACTACAACATCCAGAAAGAGTCCACCCTGCACCTGGTA
CTCCGTCTCAGAGGGTGMASSRVDYPYDVPDYAEFTMQIFVKTLTGKTITLEVEPS
DTIENVKAKIQDKEGIPPDQQRLIFAGKQLEDGRTLSDYNIQKESTLHLVLRLRG 
 
10716.1 MW 
 
 
 
2-pTyb2HAUb –was used for generating of HAUb-K48-UIPP, HAUb-K63-UIPP. 
 
ATGATCGATGCCTACCCATACGACGTACCAGACTACGCACATATGCAGATCTTC
GTCAAGACGTTAACCGGTAAAACCATAACTCTAGAAGTGGAACCGAGCGATACC
ATCGAAAACGTGAAAGCGAAAATCCAGGATAAAGAAGGCATCCCGCCGGATCA
GCAGCGTCTGATCTTTGCGGGCAAACAGCTGGAAGATGGCCGCACCCTGTCTG
ATTATAACATCCAGAAAGAGTCGACCCTGCATCTGGTCTTAAGACTGCGTGGGT
MIDAYPYDVPDYAHMQIFVKTLTGKTITLEVEPSDTIENVKAKIQDKEGIPPDQQRLIF
AGKQLEDGRTLSDYNIQKESTLHLVLRLRG 
 
10159.6 MW 
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10.2 Synthesis details of C-terminal electrophilic Glycine Analogs 
N-tert-butyloxycarbonyl (Boc)-glycinal (2). 
 
Primary and secondary alcohols are rapidly oxidized by SO3-pyridine complex in 
DMSO in the presence of triethylamine1. Triethylamine (7.8 ml, 55.8 mmol) was 
added to a solution of N-Boc-glycinol (3 g, 18.6 mmol) in dichloromethane (60 ml) at 
0°C. SO3-pyridine (8,9 g, 55,8 mmol) was first dissolved in DMSO and pyridine (0.24 
ml, 2.97 mmol) was added. After 10 minutes the SO3-pyridine in DMSO was added 
dropwise to the N-Boc-glycinol solution at 0°C, upon which the solution turned from 
clear to yellow. The ice bath was removed and the solution stirred for a further 30 min 
at room temperature. The reaction mixture was poured into 180 ml ice cold brine. 
After removal of the dichloromethane layer, the aqueous layer was extracted with 
diethyl ether (3x120 ml). The combined organic layers were washed with ice cold 
NaHSO4 solution (1 M, 1 x 42 ml) and with ice cold brine (2 x 42 ml). The organic 
layer was dried over MgSO4 anhydrous, filtered and concentrated under vacuum. A 
silica gel column was used to purify the product. The aldehyde was eluted with 20% 
ethyl acetate in dichloromethane and isolated with 68% yield (2.0 g, 12.6 mmol). The 
aldehyde was either used immediately in the following reaction or stored at -70°C. 
 
 
 
 
 
 
 
 
 
 
 
 
1 2
SO3-pyridine, TEA, DMSO, DCM
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N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid methylester (VME, 3). 
Na2CO3, THF
32  
K2CO3 (651 mg, 4.71 mmol) was suspended in THF (10 ml). Trimethyl 
phosphonoacetate (858 mg, 4.71 mmol) was dissolved in THF (1 ml) and added 
dropwise to the K2CO3 slurry at room temperature. The solution was stirred for 60 
min at room temperature. 500 mg (3.14 mmol) N-tert-butyloxycarbonyl (Boc)-glycinal 
(2) was dissolved in THF (2 ml) and added dropwise to the solution at room 
temperature. After stirring overnight at room temperature, water (10 ml) was added to 
the solution. After removal of the THF with a rotary evaporator, dichloromethane (15 
ml) was added. The organic layer was separated and washed with 2% HCl, 10% 
NaHCO3  and dried over MgSO4 anhydrous, filtered and concentrated to yield 3, 
which was further purified using silica gel chromatography. Compound 3 was eluted 
with 10% ethyl acetate in dichloromethane to yield  550 mg ( 2.56 mmol, 82%) of the 
purified compound. 
 
N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid ethylester (VEE, 4). 
Na2CO3, THF
42  
K2CO3 (390 mg, 2.82 mmol) was suspended in THF (10 ml). Triethyl 
phosphonoacetate (632 mg, 2.82 mmol) was dissolved in THF (1 ml) and added 
dropwise to the K2CO3 slurry at room temperature. The solution was stirred for 60 
min at room temperature. 300 mg (1.88 mmol) N-tert-butyloxycarbonyl (Boc)-glycinal 
(2) was dissolved in THF (2 ml) and added dropwise to the solution at room 
temperature. After stirring overnight at room temperature, water (10 ml) was added to 
the solution. After removal of the THF with a rotary evaporator, dichloromethane (15 
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ml) was added. The organic layer was separated and washed with 2% HCl, 10% 
NaHCO3  and dried over MgSO4 anhydrous, filtered and concentrated to yield 4, 
which was further purified using silica gel chromatography. Compound 4 was eluted 
with 10% ethyl acetate in dichloromethane to yield  268 mg (1.17 mmol, 62%) of the 
purified compound. 
 
N-tert-butyloxycarbonyl-(E)-4-amino-3-methyl-2-butenoic acid ethylester 
(MVEE, 5). 
Na2CO3, THF
52  
 
K2CO3 (390 mg, 2.82 mmol) was suspended in THF (10 ml). Triethyl-2-
phosphonopropionate (672 mg, 2.82 mmol) was dissolved in THF (1 ml) and added 
dropwise to the K2CO3 slurry at room temperature. The solution was stirred for 60 
min at room temperature. 300 mg (1.88 mmol) N-tert-butyloxycarbonyl (Boc)-glycinal 
(2) was dissolved in THF (2 ml) and added dropwise to the solution at room 
temperature. After stirring overnight at room temperature, water (10 ml) was added to 
the solution. After removal of the THF with a rotary evaporator, dichloromethane (15 
ml) was added. The organic layer was separated and washed with 2% HCl, 10% 
NaHCO3  and dried over MgSO4 anhydrous, filtered and concentrated to yield 5, 
which was further purified using silica gel chromatography. Compound 5 was eluted 
with 5% ethyl acetate in dichloromethane to yield 140 mg (0.575 mmol, 31%) of the 
E-/Z-mixture of 5. Preparative HPLC was used to separate the E- and Z-isomers 
(Nucleodur C18, 5µm, 250x21 mm column, isochratic flow of 55/45 acetonitrile/water 
at 12ml/min. The E-isomer had a retention time of 17 min and the Z-isomer of 21 min. 
93mg (0.382 mmol, 20%) of the purified E-isomer of 5 were isolated. 
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N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid (VA, 6). 
n-BuLi, THF, -78°C
62  
n-Buthyllithium (4.8 ml, 1.6 M in hexane, 7.54 mmol) was dissolved in THF (12 ml) at 
-78°C. Diethyl phosphonoacetic acid was dissolved in THF (5 ml) and added 
dropwise to the nBuLi solution at -78°C. The solution turned slightly yellow and was 
stirred for 30 min at -78°. N-tert-butyloxycarbonyl (Boc)-glycinal (2) was dissolved in 
THF (3 ml) and added dropwise to the solution at -78°C. After stirring for 3h at room 
temperature water (12 ml) was added to the solution. The organic layer was 
separated and washed with 10% NaHCO3 (2 x 10 ml), the combined aqueous layers 
were then acidified to pH 3.5 with conc. HCl and extracted with diethyl ether (3 x 18 
ml). The combined organic layers were dried over MgSO4 anhydrous, filtered and 
concentrated to yield 6, which was further purified using silica gel chromatography. 
Compound 6 was eluted with 20% ethyl acetate in dichloromethane containing 1% 
acetic acid to yield 389 mg (1.93 mmol, 51%) of the purified compound. 
 
 
N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid fluoroethylester (VFEA, 7). 
DIC/HOBt
6 7
 
50 mg (0.248 mmol) of 6 were dissolved in DMF abs., activated with DIPEA (130 µl, 
0.745 mmol), EDC (71.5 mg, 0.375mmol) and HOBt anh. (50.4 mg, 0.375 mmol). 2- 
fluoroethylamine hydrochloride (37.1 mg, 0.375 mmol) were added and the solution 
was stirred overnight at room temperature. The reaction was quenched by adding 
phosphate buffer (pH7). After addition of saturated NH4Cl solution, the solution was 
extracted with ethyl acetate (3x5 ml). The combined ethyl acetate layers were 
washed with a saturated NaCl solution and dried over MgSO4 anhydrous, filtered and 
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concentrated to yield 7, which was further purified using silica gel chromatography. 
Compound 7 was eluted with 50% ethyl acetate in dichloromethane to yield 56.7 mg 
(0.23 mmol, 93%) of the purified compound. 
 
 
N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid trifluoroethylester (VF3EA, 
8).  
DIC/HOBt
6 8
 
 
50 mg (0.248 mmol) of 6 were dissolved in DMF abs. (2.4ml), activated with DIPEA 
(130 µl, 0.745 mmol), EDC (71.5 mg, 0.375mmol) and HOBt anh. (50.4 mg, 0.375 
mmol). 2,2,2-Trifluoroethylamine hydrochloride (29µl mg, 0.373 mmol) were added 
and the solution was stirred overnight at room temperature. The reaction was 
quenched by adding phosphate buffer (pH7). After addition of saturated NH4Cl 
solution, the solution was extracted with ethyl acetate (3x5ml). The combined ethyl 
acetate layers were washed with a saturated NaCl solution and dried over MgSO4 
anhydrous, filtered and concentrated to yield 8, which was further purified using silica 
gel chromatography. Compound 8 was eluted with 50% ethyl acetate in 
dichloromethane to yield 44.3 mg (0.157 mmol, 63%) of the purified compound. 
 
Peptide synthesis of Ac-seq1-X-seq2 (9). 
Peptides were synthesized on a 25 µmol scale using an automated multiple peptide 
synthesizer (Syro I from MultiSynTech, Witten, Germany). The sequences were 
assembled as C-terminal amide on polyoxyethylene-grafted polystyrene resin, to 
which the Rink amide linker was attached (TentaGel S RAM resin, 100 mg, 0.25 
mmol g−1). Five equivalents of Fmoc-amino acid/DIC/HOBt (0.36 M in DMF) were 
coupled (2 × 1 h + capping with acetic anhydride/pyridine/DMF 1:2:3) for each 
coupling cycle. Lysine was incorporated with a Mtt-protecting group for the ε-amino 
group in its side chain. The N-terminus was acetylated using acetic 
anhydride/pyridine/DMF (1:2:3, 30min).  
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Mtt group cleavage and coupling of (E)-4-amino-2-butenoic (6) acid and 
isolation of (10). 
seq. 2seq. 1 seq. 1 seq. 2-K- -K-Ac- Ac- -NH2
1. 3%TFA, 5%TIPS,
    92% DCM
2. DIC/HOBt
3. 90% TFA,
5% TIPS, 5% H2O
69 10  
For Mtt group cleavage from the ε-amino group of lysine resins were swollen in DCM 
and treated with 3% TFA, 5% TIPS, 92% DCM (1 ml, 8 x 20 min). The resin was then 
washed with DCM (1 ml), 5% DIPEA/DCM (1ml), DCM (1 ml) and DMF anhydrous 
(1ml). 5 eq. of N-tert-butyloxycarbonyl-(E)-4-amino-2-butenoic acid (3) (relative to the 
loading of the resin: 125 µmol, 25.2 mg) were pre-activated for 1h with DIC (5 eq., 
125 µmol, 19.4 µl) and HOBt anhydrous (5.5 eq., 137.5 µmol, 18.6 mg) in 0.5 ml 
DMF anhydrous. The solution was added to the resin and shaken for 5d. Peptides 
were cleaved from the resin as C-terminal amides using a mixture of TFA, DCM, 
water, and triisopropylsilane (70:20:5:5) for four hours, precipitated in a cold 1:1 
mixture of tert-butylmethyl ether and cyclohexane, extracted with water, and 
lyophilized. Crude peptides were purified by preparative HPLC on a 250 × 10 mm 
NUCLEOSIL RP18 column and characterized by LC-MS. 
 
Peptide Sequences and HPLC/ESI-MS 
K48-isopeptide thiol reactive trap: 
Ub(42-54): Ac-RLIFAG-K48(VA)-QLEDGR-NH2 
ESI-MS (m/z): [M+2H]2+ calc.: 813.98, found: 814.0 
 
K63-isopeptide thiol reactive trap: 
Ub(54-72): Ac-RTLSDYNIQ-K63(VA)-ESTLHLVLR-NH2 
ESI-MS (m/z): [M+2H]2+ calc.: 1205.69, found: 1205.8 
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10.3 Identified DUBs using modulated active site directed probes 
(4.1.1) 
 
Unique spectral counts of DUBs after an overnight α-HA immunoprecipitation using indicated 
HAUb derived probes. 
Accession Number HAUb-VME HAUb- VEE HAUb-MVEE 
USP5 64 57 39 
USP4 15 26 15 
USP47 21 28 25 
USP7 19 27 10 
USP14 25 36 13 
USP9X 2 9 2 
USP15 13 24 9 
USP16 6 6 6 
UCHL3 15 38 15 
UCHL5 11 18 3 
USP8 2 5  
USP19 1 3 2 
OTUB1 6 16 10 
UCHL1 20 12  
EIF3F 8 16 8 
EIF3H 5 13 5 
PSD7 8 8 16 
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10.4 Identified DUBs of profiling experiment using new active site 
directed probe HAUb-VFEA 
 
Accession 
Number 
MW A549 EL-4 HeLa Jurkat MCF-7 
ATXN3 42 2 4 5 8 7 
BAP1 80 17 5 24 15 19 
CSN5 38  1 2 4  
CYLD 107 4 20 7 12 6 
EIF3F 38    3  
EIF3H 40 1 1 1 1 1 
JOS1 23   1 2  
JOS2 23     2 
OTU6B 34 8 5 10 9 6 
OTU7A 101  1 5   
OTU7B 93 19 13 37 14 39 
OTUB1 31  6 1  8 
OTUB2 27 2 2  6 3 
OTUD3 20   1   
OTUD4 123  3    
OTUD5 61   2   
PRO8 274 7 6 5 31 9 
PSMD14 35 1 3  2 1 
PSMD7 37  1 2 1  
UCHL1 25 15 5    
UCHL3 26 8 13 11 15 10 
UCHL5 38 26 6 27 25 26 
USP1 88   14 2 3 
US14 56 38 15 41 40 43 
USP10 87 19 7 26 18 27 
USP11 110 28  30 52 39 
USP12 43 6  5 3 6 
USP15 112 48 14 56 46 60 
USP16 94 20 3 29 24 30 
USP17L2 88  9 14 2 3 
USP19 146 31 23 52 42 44 
USP2 68   1 1 1 
USP20 102 4 1 13 17 25 
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Accession 
Number 
MW A549 EL-4 HeLa Jurkat MCF-7 
 
USP21 63    4  
USP22 60 15  7 13 6 
USP24 294 35 11 89 78 49 
USP25 122 34 17 39 21 32 
USP27 50 1   1  
USP28 122 34 2 50 17 33 
USP29 98  1    
USP3 59 1  9 3 4 
USP30 59 2  6 11 9 
USP31 147 2   1 6 
USP32 182 13 1 28 20 63 
USP33 107 30 5 39 8 14 
USP34 404 12 1 40 15 11 
USP35 113  1 4 2 24 
USP36 123 4  3 15  
USP37 110 1  11 11 6 
USP38 117 6 22 6 9 8 
USP39 65    1  
USP4 109 16 26 33 47 45 
USP40 140 4  7  25 
USP42 145 4  3 7 6 
USP43 123 1  1  6 
USP45 90    2  
USP46 42 7 7 9 9 9 
USP47 157 36 30 79 71 68 
USP48 119 35 4 48 45 48 
USP5 96 44 37 58 44 57 
USP54 177 1     
USP7 128 74 65 96 86 86 
USP8 128 43 27 54 26 54 
USP9X 297 108 19 128 104 116 
USP9Y 291    3 2 
VCIP1 134 8 1 20 14 1 
ZRANB1 81   1 1 1 
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10.5 Comparison of identified DUBs using HAUb-VME or 
HAUb-VFEA 
 
VME HAUb-VME & 
HAUb-VFEA 
HAUb-
VFEA 
Reference 
USP13   
128
 
A20   
165
 
 USP2  
164
 
 USP3  
164
 
 USP4   
128
 
 USP5  
128 
 USP7  
128 
 USP8  
128 
 USP9X  
128 
 USP10  
128 
 USP11  
128 
 USP12  
128 
 USP14  
128 
 USP15  
128 
 USP16  
128 
 USP19  
128 
 USP20  
165
 
 USP22  
202
 
 USP24  
128 
 USP25  
128 
 USP28  
128 
 USP29  
203
 
 USP30  
165 
 USP32  
165 
 USP36  
164
 
 USP37  
164
 
 USP38  
165
 
 USP40  
165 
 USP46  
165 
 USP47  
203
 
 USP48  
165
 
 CYLD  
128 
 UCHL1  
128 
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VME HAUb-VME & 
HAUb-VFEA 
HAUb-
VFEA 
Reference 
 UCHL3  
128 
 UCHL5  
128 
 OTUB1  
128 
 OTUB2  
165
 
 OTUD4  
203 
 OTUD5  
203 
 OTU6B  
203 
 OTU7A  
203 
 OTU7B  
203 
 VCIP135  
203 
 JOS1  
203 
 JOS2  
203 
  USP1  
  USP9Y  
  USP17L2  
  USP21  
  USP27  
  USP31  
  USP33  
  USP34  
  USP35  
  USP42  
  USP43  
  USP45  
  BAP1  
  OTUD3  
  ZRANB1  
  Ataxin 3  
  USP39  
  USP54  
  CSN5  
  EIF3F  
  EIF3H  
  PRO8  
  PSMD14  
  PSMD7  
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10.6 Deubiquitinating enzymes modified with branched Ubiquitin Isopeptide Probes (UIPPs) by 
applying functional proteomics 
 
Modified proteins were immunoprecipitated and sequenced as described in the text. Peptide matches were assigned using the 
Mascot2 W2K3 2.3.02 (Matrix Science) the considered significance was determined as described in the text above. SwissProt 
accession numbers are for human sequences. Number of unique peptides gives the number of unique peptides identified for 
each protein. The greatest observed sequence coverage is given by Percentage sequence coverage. Spectral count numbers 
were normalized using Proteome-Software Scaffold 3.0 which are represented as Quantative values. 
 
   No. of unique peptides Percentage sequence 
coverage [%] 
Quantative value  
Identified 
DUBs 
Accession Number MW [kDa] UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME 
USP47 UBP47_HUMAN 157  21 20 27 19 18 22 48 56 34 
USP7 UBP7_HUMAN 128  23 5 44 22 5.1 45 46 6 98 
USP9X USP9X_HUMAN 292  30 19 34 15 8.5 17 35 25 34 
USP5 UBP5_HUMAN 96  18 5 25 26 8.5 31 33 8 62 
USP11 UBP11_HUMAN 110  18 14 33 22 17 40 29 32 66 
USP15 UBP15_HUMAN 112  14 17 18 18 20 21 28 46 30 
UCHL5 UCHL5_HUMAN 38  12 8 16 45 28 59 26 15 32 
USP19 UBP19_HUMAN 146 10 14 15 9,6 15 15 22 39 19 
UCHL3 UCHL3_HUMAN 26  6 4 10 32 23 46 20 16 26 
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Identified 
DUBs 
Accession Number MW [kDa] UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME 
 
USP4 UBP4_HUMAN 109 9 8 23 12 11 38 16 20 33 
USP14 UBP14_HUMAN 56  11 9 27 30 25 55 13 13 96 
USP8 UBP8_HUMAN 128 6 6 14 7 7 16 11 13 21 
USP24 UBP24_HUMAN 294 8 6 26 3.90 2.9 14 8 8 23 
USP16 UBP16_HUMAN 94  5 5 6 6.60 8.3 9,7 6 9 7 
USP38 UBP38_HUMAN 117 5 12 12 5 12 13 5 15 9 
USP36 UBP36_HUMAN 123 4 5 3 3.70 4.5 3.4 4 6 3 
USP42 UBP42_HUMAN 146 3 1 4 2.30 0.75 4.2 4 3 4 
USP10 UBP10_HUMAN 87  2 1 8 3.30 1.5 11 3 1 16 
USP20 UBP20_HUMAN 102 2 2 2 3.40 3.4 3.1 3 4 2 
BAP1 BAP1_HUMAN 80  2 3 5 2.70 4.1 7.7 2 5 4 
EIF3F EIF3F_HUMAN 38 4 2 3 13 7 9 4 3 2 
PRPF8 PRP8_HUMAN 274 11 9 9 4.8 4.4 4.4 12 11 7 
USP28 UBP28_HUMAN 122 2  8 2.2  8.9 2  9 
USP12 UBP12_HUMAN 43  1  6 2.2  20 1  5 
USP22 UBP22_HUMAN 60  1  2 1.5  5.3 1  2 
USP48 UBP48_HUMAN 119   23   24   23 
VCPIP1 VCIP1_HUMAN 134   12   14   12 
CYLD CYLD_HUMAN 107   7   9.6   6 
USP25 UBP25_HUMAN 122   9   9.3   7 
USP32 UBP32_HUMAN 182   7   4.8   9 
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Identified 
DUBs 
Accession Number MW [kDa] UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME UIPP-
K48 
UIPP-
K63 
VME 
 
USP37 UBP37_HUMAN 110   4   5.5   3 
USP46 UBP46_HUMAN 42    2   19   5 
USP34 UBP34_HUMAN 404    2   0.79   2 
USP3 UBP3_HUMAN 59    2   5.6   2 
Ataxin-3 ATX3_HUMAN 42   5   19   9 
Josephin-1  JOS1_HUMAN 23   2   10   2 
OTU6B OTU6B_HUMAN 34   6   19   9 
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10.7 Represantative example of the fraction analysis using 
mass spectrometry (MALDI-TOF) 
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